Home Blog Page 90

Nigeria Loses Over $2bn Annually to Medical Tourism —Association

0

 

Nigeria Loses Over $2bn Annually to Medical Tourism —Association

 

Nurses, under the auspices of the University Graduates of Nursing Science Association, have expressed worry that Nigeria loses an estimated $2 billion (N1.1trillion) annually to medical tourism.

This is contained in a communiqué issued in Abakaliki on Thursday at the end of a two-day national conference of the association, held at the auditorium of the Alex Ekwueme Federal Teaching Hospital, Abakaliki.

The communique made available to journalists was signed by Chief Solomon Egwuenu and Goodluck Nshi, the association’s National President and National Secretary respectively.

The association lamented the poor global ranking of the Nigerian health sector, which according to the association in the 1960s was ranked among the 10 best in the world.

The communique reads in part: “How do we come to terms with the Federal Ministry of Health’s estimation that Nigeria loses about $2 billion (N1.1 trillion naira) annually to medical tourism?

“It is heart wrecking, especially when it is obvious that this money if put together over the next five years and deployed for the upgrade of our health facilities, health research capabilities, and healthcare infrastructure, can launch our health system to be among the best five in the world.”

UGONSA regretted that the Nigerian health system once revered globally was now being celebrated that its ranking has improved from 187 out of 191 countries two decades ago to 163 out of 191 countries today.

“Our hospitals will be fixed to be in the world-class ranking any day our political class starts getting treatment from our hospitals.

“It is high time medical tourism became a topic for the acceptance or rejection of politicians at the polls.

“The poor performance of our health system in global ranking has never been the fault of our healthcare professionals.

“It is a systematic fault of not putting the right facilities and motivation in place by the country’s successive leadership.

“To enable our healthcare professionals to replicate the type of wonders they have been performing when they travel abroad in our own health system.

“The monies wasted on medical tourism are enough to rejig our health system and make a competing payment to the healthcare professionals that will dissuade those currently practising in the country from contemplating going abroad.

“If our health system is not good for you, our political system should not be good for you.”

On the prevailing insecurity in the country, the association called on both the state and federal governments to intensify campaigns against insecurity. 

(NAN)

FCT Schools to Prioritise Menstrual Hygiene Management

0

 

FCT Schools to Prioritise Menstrual Hygiene Management

 

School principals in the FCT on Thursday pledged to prioritise Menstrual Hygiene Management through the provision of Water, Sanitation and Hygiene (WASH) facilities to encourage attendance and boost confidence of female students.

They made the pledge at a meeting on the baseline dissemination findings on the impact of the “Always keeping Girls in School” (AKGIS) project organised by an NGO, Tabitha Cumi Foundation in Abuja.

Mr James Oladela, the Principal, Junior Secondary School (JSS) Ushafa, said findings from the baseline research had exposed them to the difficulties female students face during their menstruation.

“For me, it is an eye opener, especially for those of us who are male principals on the need to open our hearts and be more accessible to the girl child, especially our dear students as it relates to the menstrual cycle.

“Every myths that used to surround menstruation for the girls has been removed by programmes of Tabitha Cumi, especially through the training, the advocacy visits and what have you,” he said.

According to him, he will ensure that toilets are built with adequate water supply in the school environment to enable the students practice menstrual hygiene management.

Also, Mr Joshua Afolabi, the Principal, JSS Kuchigoro, said the training by the NGO has equiped him with more knowledge on menstrual hygiene management.

“I never knew the importance of water to menstrual hygiene, but today I have the knowledge and the importance, and equally the importance of toilet to hygiene.

“Where I am in Kuchigoro, we don’t have toilets for students and I pity myself after today’s training because by God’s grace, within my power, I will do everything to build toilets, even if it is for girls,” he said.

Meanwhile, Dr Safiya Tamanuwa, representing Universal Basic Education Board (UBEB), said the board would ensure available resources for the construction of additional toilets and WASH facilities in schools.

Tamanuwa said additional toilets and access to WASH facilities would protect the dignity of the girl-child during menstruation and reduce absentism from school.

She said: “They are not adequate because of the large population, at least there are facilities there.

“So what we are saying is on improving on them and make additional ones and as soon as resources are made available UBEB will do it as they are doing it stage by stage.”

On her part, Mrs Tayo Erinle Executive Director, Tabitha Cumi Foundation, said the AKGIS project was sponsored by Proctor and Gamble (P&G) to enhance girls’ knowledge and practice around reproductive health.

Erinle said the project also aim at reducing stop girls drop out and absentism due to menstruation and encourage male champions on menstrual hygiene to bring about transformational change and sustainability.

“So, the aim of this programme is to stop dropouts, attrition of girls because the attrition rates of girls is high. So the aim of this programme is to stop it so that girls can complete their cycle.

“And I think I am most excited today about the male involvement. For me, it is something that will bring about great transformation because men usually trivialise girls issues.

“But when men champion it, the change is faster, because you don’t have to struggle so much.

“And we have been able to get men in the schools, the principal, championing the cause of menstruation.

“So, we feel that at the close-out of the project, there will will be sustainability because there is a passion,” she said.

According to her, through life skills, puberty training, provision of emergency sanitary kits to help girls manage their menstrual periods with dignity, have increased their self-esteem and reduce absenteeism from school.

She explained that the project had empowered 1,500 adolescent girls in 20 Junior Secondary Schools in the FCT and 10 Junior Secondary Schools in Abeokuta, Ogun State.

Erinle added that it had also trained guidance counsellors in the 30 schools, built the capacity of 60 peer mentors, supplied sanitary pads and conducted baseline assessments in the schools. (NAN)

Ingredients used for capsulation in soft capsule should flow by gravity at a temperature Not exceeding?

7

Ingredients used for capsulation in soft capsule should flow by gravity at a temperature Not exceeding?
(a) 35°c

(b) 30°c

(c) 25°c

(d) 20°c

Studies Validate Tomato Substances Reduce Prostate Cancer Risk

1
Studies Validate Tomato Substances Reduce Prostate Cancer Risk
Fresh Tomatoes Image

Tomato, a reddish and oval-shaped vegetable, which belongs to the plant kingdom Solanum Lycopersicum, has been found to possess powerful antioxidants called carotenoids, with the potential to prevent certain types of cancers.

A study published in the National Library of Medicine titled “Lycopene/tomato consumption and the risk of prostate cancer”, found that tomato has been indicated for the prevention of prostate cancer; however, no systematic review has been reported to illustrate its effect recently.

Tomatoes are also good sources of vitamin A, which supports immunity, vision, and skin health; vitamin K, which is good for your bones; and potassium.

The researchers conducted a meta-analysis to determine the effectiveness of lycopene intake and tomato/tomato products in reducing the risk of prostate cancer.

The study led by Jinyao Chen  and his team members  Yang Song and  Lishi Zhang, compared the odds ratio (OR) of prostate cancer incidence among consumers of lower raw tomatoes and higher consumers of raw tomatoes,  versus consumption of lower levels of cooked tomatoes and higher levels of cooked tomatoes. Their findings show that tomatoes may play a modest role in the prevention of prostate cancer.

However, they noted that further research would be needed to determine the type and quantity of tomato products and their degree of protection against prostate cancer.

Another study published in the same Library of Medicine but reviewed by different researchers found that after much experiments  and studies by Mahyar Etminan  and others, eleven case-control studies and 10 cohort studies or nested case-control studies presented data on the use of tomato, tomato products, or lycopene and met their inclusion criteria.

They also found that tomato products may play a role in the prevention of prostate cancer. However, this effect is modest and restricted to high amounts of tomato intake. Further research is needed to determine the type and quantity of tomato products with respect to their role in preventing prostate cancer.

Other Health Benefits of Tomatoes

They protect heart health: Tomatoes contain an antioxidant called lycopene, which is responsible for their red color. Research suggests that in terms of heart health benefits, it’s more effective to eat tomatoes and tomato products than take lycopene supplements.

Improve your vision:  Lycopene in tomatoes is also good for your eyes. And that’s not the only peeper-protective nutrient in tomatoes; they also contain lutein and beta-carotene.

Boost digestive health: The fluid and fiber in tomatoes may be helpful if you’re prone to constipation. (According to the USDA one large tomato contains 6 ounces of fluid, and 1.5 grams of fiber.) Just be aware that in some people, the acidity from cooked tomatoes may trigger or worsen acid reflux and indigestion.

Help with diabetes management: Tomato may be a protective food for people with type 2 diabetes: In one study, people with diabetes who supplemented with cooked tomatoes for 30 days experienced a decrease in lipid peroxidation, a chain reaction in which substances called free radicals to attack fat, leading to damage that ups the risk of heart disease. This is particularly important because diabetes doubles the risk of stroke and heart attack.

Judging from the conclusions of various researchers that have conducted intensive studies and experiments on tomatoes, they have shown that high consumption of tomatoes plays a huge role in preventing prostate cancer and other diseases.

 

Natural camphor is?

10

Natural camphor is?

(a) An optically inactive aldehyde obtained from cinnamomum camphora
(b) A white dextrorotatory ketone obtained from the wood of cinnamomum camphora
(c) A white optically inactive ketone obtained form the bark of cinnamomum camphora
(d) A white volatile aldehyde obtained from the bark of cinnamomum camphora

Nigerians to access affordable surgical care — FG

0
Dr Deborah Bitrus-Oghoghorie, Consultant Grade 1, Federal Ministry of Health, Hospital Services, has said that Nigerians would began to access affordable surgical care.
Federal Ministry of Health Logo

Dr Deborah Bitrus-Oghoghorie, Consultant Grade 1, Federal Ministry of Health, Hospital Services, has said that Nigerians would began to access affordable surgical care.

Bitrus-Oghoghorie disclosed this at the Federal Medical Centre, Ebute-Metta, Lagos, on

Wednesday during an enlightenment session of medical personnel in the hospital.

According to her, National Surgical, Obstetrics, Anesthesia and Nursing Plan (NSOANP) wants to carry its policy down to state and disseminate its plan in all the 36 states so that Nigerians will know what it entails.

She said that NSOANP had to do with providing affordable, accessible and safe surgery to Nigerians that need it as part of universal health coverage.

“This is as a result of world health assembly resolution in 2015 which mandated member states to include basic and surgical care as part of universal coverage in the country.

“Federal Ministry of Health produced the plan and most of the implementation takes place at the state level.

“That is why we started the dissemination to the 36 states and the federal capital territory after approval was given at the national council of health,” she said.

Bitrus-Oghoghorie, who is also the desk officer NSOANP, Nigeria, said that every Nigerian would benefit from the plan if it was implemented because surgical services would be closer to the people.

The desk officer said that Nigerians should be able to afford basic services for surgery and such services should be safe and not make them spend beyond their means.

She said that World Health Assembly Resolution 68:15 says Surgical, Obstetrics, Anesthesia and Nursing care are important components of Universal Health Coverage.

She said that Universal Health Coverage (UHC) is complete when surgeries are fully integrated into healthcare services.

She said prevention was also possible for surgery in that one should present early with ones surgical conditions.

WHO Warns Against Use of 2 Drugs For Non-Severe COVID-19

0

Combatting COVID-19 pandemic cost the world $11tn – AfreximbankThe World Health Organisation (WHO) on Wednesday advised patients with mild or moderate cases of the Coronavirus (COVID-19) against the use of antidepressant drug, fluvoxamine, and the gout drug colchicine.

The organisation said in a statement that current indications did not justify using colchicine to treat non-severe illness, addding that fluvoxamine should not be used without clinical trials.

According to report by a WHO Guideline Development Group (GDG), the advice became necessary due to insufficient evidence of better results from the use of the drugs and their potential harm. panel of international experts in the British Medical Journal.

The report, put together by a panel of international experts in the British Medical Journal, said no recommendation was made for either drug in patients with severe or critical illness, given limited or no data.

“Fluvoxamine and colchicine are commonly used, inexpensive drugs that have received considerable interest as potential COVID-19 treatments during the pandemic.

“However, today’s recommendations against their use reflect ongoing uncertainty about how the drugs produce an effect in the body.

“Also the evidence of little or no effect on survival and other important measures, such as risk of hospital admission and need for mechanical ventilation.

“There is also a lack of reliable data on covid-19 related serious harms associated with these drugs,’’ it said.

It said that the WHO’s advice against the use of fluvoxamine except in clinical trials was informed by data from three randomised controlled trials (RCTs) involving over 2,000 patients.

“Their strong advice against colchicine was based on data from seven RCTs involving 16,484 patients,’’ it said.

It said that after thoroughly reviewing the evidence, the panel, which included experts from around the world and four patients who had had COVID-19, it concluded that almost all well-informed patients would choose not to receive either fluvoxamine or colchicine therapy for COVID-19.

It said the panel noted that none of the included studies enrolled children, so the applicability of these recommendations to children is uncertain.

It, however, said the panel did not see reason why children with COVID-19 would respond any differently to treatment with fluvoxamine or colchicine.

“Today’s recommendations are part of a living guideline, developed by the organization with the methodological support of MAGIC Evidence Ecosystem Foundation, to provide trustworthy guidance on the management of covid-19.

“Living guidelines allow researchers to update previously vetted and peer reviewed evidence summaries as new information becomes available,’’ it said.

According to the report, previously, WHO has made a strong recommendation for use of nirmatrelvir and ritonavir, and conditional recommendations for sotrovimab, remdesivir and molnupiravir for high-risk patients with non-severe COVID-19.

The report said that for patients with severe COVID-19, WHO strongly recommends corticosteroids, with the addition of IL-6 receptor blockers or baricitinib.

WHO also warned against the use of convalescent plasma, ivermectin, and hydroxychloroquine in patients with COVID-19 regardless of disease severity.

The Normal Range of Fasting Blood Glucose is?

14

The Normal Range of Fasting Blood Glucose is?

a. 3-4mmol/L(55-75 mg/dL)

b. 4-8 mmol/L(75-150 mg/dL)

c. 8-10 mmol/L(150-180 mg/dL)

d. 5-6 mmol/L(90-110 mg/dL)

NAFDAC Warns Against Use of YW Cosmetics Glycolic Acid

1
NAFDAC warns against use of YW cosmetics glycolic acid
NAFDAC Logo

The National Agency for Food and Drug Administration and Control (NAFDAC) has warned against the use a cosmetic product, YW Cosmetics Glycolic Acid containing 70 per cent content.

The warning is contained in a public alert with No. 032/2022, signed by the Director-General of the agency, Prof. Moji Adeyeye, on Tuesday ìn Abuja.

Adeyeye stated that the agency was equally informed of the product by
German Federal Office of Consumer Protection and Food Safety (BVL).

According to her, 70 per cent of glycolic acid is a strong acidic alpha hydroxyl-acid (AHA) and is the most popular used in skin care.

She said that the product was manufactured from sugar cane, and “is the smallest AHA, and the most effective at getting into the skin”.

“It is a substance that chemically exfoliates the skin by dissolving dead skin cells and oils.

“Products containing AHAs are marketed for a variety of purposes, such as smoothing fine lines and surface wrinkles, improving skin texture and tone, unblocking and cleansing pores, and improving skin condition in general.

“Alpha hydroxy acids can also cause mild skin irritation, redness, swelling, itching, and skin discolouration.

“Facial peels left on the skin for periods longer than recommended can cause severe burns to the skin.

“The product comes in a 50ml bottle and is traded online without a batch and lot identification number,” Adeyeye said.

According to her, NAFDAC implores consumers to exercise caution in the use of Y the cosmetics.

“Healthcare professionals, consumers and patients are encouraged to report adverse events related to the use of this product to the nearest NAFDAC office, NAFDAC PRASCOR on (20543 TOLLS FREE from all networks).

“The public is also encouraged to report adverse effects”.

NAN

Drug Abuse: Expert Advises Parents to Educate Children about Healthy Choices, Consequences

0
Drug Abuse: Expert advises parents to educate Children about healthy choices, consequences
Drug Abuse Substances

A Clinical Psychologist, Ekiti State University Teaching Hospital, Dr Adedotun Ajiboye, has advised parents to prevent drug abuse by talking to children about the consequences of the act and the importance of making healthy choices.

The Psychologist gave the advice in a telephone interview with the News Agency of Nigeria (NAN) on Tuesday in Abuja.

According to him, drug abuse is a social menace in the society that is ruining many lives, especially health of the users, families, communities, labour organisations and nations across the world.

“Talk honestly with your child about healthy choices and risky behaviours is very important.’’ Ajiboye advised.

He said that most of the social vices in the society such as kidnapping, cultism, armed robbery, rape, cyber-crime, domestic and societal violence, were all connected to drug abuse.

“People abuse both illicit drugs such as marijuana, cocaine, heroine among others and licit ones, such as tramadol, cigarette, alcohol and pentasocine psychoactive substances.

He said many factors  were recognised as major predictors of drug abuse in the generation,, including poor parenting, exposure to technology and the environment.

According to him, for poor parenting, parents using any of the psychoactive substances can easily influence their children to use as well.

He said a theory in psychology-social learning confirmed this, noting that when a child observed the parents using psychoactive substances, he or she could emulate them.

According to him, some environment can be seen as rearing grounds for drug addicts, adding that at such places, psychoactive substances are readily available, making people to have access and use the substances.

Ajiboye said that for technology, social media had also been recognised as platforms where people learnt how to use psychoactive substances, because many posts or advertisements on the internet promoted drug abuse.

He explained that the best way that parents could assist their children to stay safe online, was to ensure that they were familiar with technology themselves.

“One of the biggest fears for parents is that their child could either meet inappropriate people, or engage in inappropriate activity online,’’ Ajiboye said.

According to him, many parents choose to monitor their children’s online activities and whether or not to let the child know.

On the impact of negative family environment had on the development of a child, he identified poor language development by age three and later behaviour problems, as some of the challenges.

Others, he said, were aggression, anxiety or depression, deficits in school readiness and impaired cognitive development from age three to 24.

He noted that such unsuitable home environment were not healthy for the development of children.

Ajiboye advised that taking a week break from social media platforms might improve the well-being of children and reduce symptoms of depression and anxiety. (NAN)(www.nannews.ng)

Cardiologists List 10 Means of Stroke Prevention

0

 

 

Cardiologists List 10 Means of Stroke Prevention
Illustration of stroke. Image credit: Mayo Clinic

Towards curbing the prevalence of stroke and other cardiovascular diseases in the country, consultant cardiologists from the Federal Medical Centre, Asaba and Federal Medical Centre, Owo, have advised Nigerians on the importance of adopting healthy lifestyles to cut their risk of stroke and blood clot.

The medical experts who highlighted ten proven natural means of preventing stroke, classified risk factors for developing stroke into modifiable and non-modifiable factors. Modifiable risk factors according to them are hypertension, diabetes, smoking, immodest alcohol use, heart diseases- arrhythmias, heart failure, cardiomyopathy, valvular heart disease, congenital heart disease, infective endocarditis, etc, sickle cell disease, HIV, among others.

In an exclusive interview with Consultant Physician and Cardiologist, Dr Valentine Nnaemeka Amadi, of FMC Owo, he itemised lifestyle modifications that can aid prevention of stroke to include:
low salt diet,
low cholesterol diet,
adequate water intake,
adequate intake of fruits and vegetables,
moderate exercise which may need to be prescribed in some cases,
no smoking,
reduced or no alcohol intake,
regular medical check-ups and follow up as needed,
avoiding prolonged immobilisation, and
early risk stratification of suspected cases with anticoagulants.

He averred that uncontrolled hypertension is the commonest cause of stroke, while conditions of the heart leading to stasis such as heart failure and arrhythmias, also known as irregular heart rhythm, for instance atrial fibrillation, are other causes of stroke.

Dr Amadi further mentioned the non-modifiable risk factors for stroke to include: advancement in age, family history, previous history of stroke, male gender, as more males have higher risk of stroke than females, and black race.

Affirming the views of Amada, Dr Agoke Adekunke, consultant cardiologist, FMC Owo, identified the formation of blood clots as a risk factor for stroke, with common causes such as heart diseases, cancers, obesity and those who have undergone major surgery. In addition, he said families with inherited blood disorder like haemophilia, are also at risk.

Dr Adekunle, who also spoke with Pharmanewsonline in an exclusive interview emphasised the essence of early diagnosis and treatment of stroke, saying “It’s very important that when certain disease conditions which can lead to stroke are suspected, efforts must be put in place to begin early treatment. For instance, people who have atrial fibrillation (AF) must be risk stratified soonest to begin the blood thinners that may help.

“Also in the society at large, cutting down on weight if obese, avoiding prolonged immobilisation by initiating early ambulation if admitted on beds”.

Explaining the relationship between atrial fibrillation (AF) and stroke, he described AF as a disorder of heart rythms causing the heart to beat abnormally and the greatest risk associated with it is stroke. Many factors can make one to be at risk of stroke when there is AF such as those with underlying co-morbidities like hypertension, heart failure, diabetes mellitus and previous heart attacks. In addition, he said the older the patient and gender, more common with the males above 75 years and females above 65 years.

Again Dr Amadi stated that there are two types of stroke- Ischemic stroke and haemorrhagic stroke. While he differentiated the types of stroke according to their occurrences, he said clot formation falls under ischemic stroke which is divided into thrombotic and embolic stroke. Thrombotic stroke involves formation of plaques within the blood vessel wall which causes narrowing of the vessel diameter leading to poor perfusion of that region of the brain it supplies.

“In this case, the plaque does not get detached from the vessel wall. If it does, it has become an embolus (clot) giving rise to an athero-embolic stroke, a type of embolic stroke. But if the clot was formed within the heart as previously described, it’s a cardio-embolic stroke, the second type of embolic stroke”, he stated.

The cardiologist simply refers to haemorrhagic stroke as an acute bleeding within the brain caused by a ruptured blood vessel, and is most commonly caused by uncontrolled high blood pressure.

Which of the following is diamorphine?

12
PANS QUIZ
Pans

Which of the following is diamorphine?

 a. Codeine        

  b. Thebaine       

  c. Fentanyl       

d. Heroin

Paracetamol Abuse Could Damage Liver, Health Commissioner Warns Nigerians

0
Paracetamol Abuse Could Damage Liver,Health Commissioner Warns Nigerians
Paracetamol Drug

The Commissioner for Health and Human Services in Benue, Dr. Joseph Ngbea, has cautioned Nigerians against abusing drugs like paracetamol.

Ngbea stated this on Monday while speaking during the War Against Drug Abuse programme, organised by Eunice Spring of Life Foundation, in partnership with the National Drugs Law Enforcement Agency in Makurdi.

The commissioner stressed that the abuse of paracetamol could affect the liver negatively.

He urged Nigerians to keep strictly to prescriptions to avoid abuse of drugs and subsequent damage to their body systems.

He further disclosed that the Ministry in partnership with ESLF and NDLEA would put up a proposal to the state government to build rehabilitation centres in all the three Senatorial Districts of the state.

He pledged that the ministry would sustain its partnership with ESLF and NDLEA to ensure that WADA achieved success in the state.

Meanwhile, Governor Samuel Ortom of Benue has attributed the rising cases of insecurity in the country to the increase in substance abuse.

Ortom said drug abuse had dealt heavily with society, stressing that all Nigerians must come together to tackle it head-on.

He commended his wife, Dr. Eunice Ortom, for championing the fight against drug abuse in the state and country at large.

Also speaking, Dr. Eunice Ortom advised Nigerians to rub their minds more on how to tackle the menace of drug abuse.

“Drug abuse is a global challenge and people should not allow it to ruin them, steal their joy or happiness.

“For President Muhammadu Buhari to launch WADA, it means that the menace needs to be tackled with all seriousness and determination.

“Almost everyone is affected by drug abuse in one way or the other,” she said.

She encouraged people not to write victims off rather, they should help them because they needed love, care, affection, assistance, advice, prayers, encouragement, and counselling.

The state Commander, NDLEA, Mrs. Esther Musa, lamented that the cultivation of cannabis had taken over the cultivation of yams, cassava, maize, and others in the state.

Musa called on all and sundry to assist the agency to nip the menace in the bud by volunteering information to her.

The Coordinating Programme Officer, ELSF, Miss Karen Yankyaa, said that a survey conducted in 2020 revealed that 14.4m Nigerians used and abused drugs.

Gynaecologist Attributes Early Menopause to Health Issues, Genetic Reasons

0

 

Gynaecologist Attributes Early Menopause to Health Issues, Genetic Reasons
Symptoms of menopause. Image Source: EveryDay Health

A gynecologist,  Dr Prosper Igboeli, has attributed early menopause in young women to health issues and genetic reasons.

Igboeli said this in an interview with the News Agency of Nigeria (NAN) in Abuja.

He, however, advised young women who experienced early menopause to take a look at their genetic pool, health issues for the causes and possible remedy.

According to him, menopause occurs between 48 and 55 years.

Menopause is the transition period in a woman’s life when her ovaries stop producing eggs, her body produces less estrogen and progesterone, and menstruation becomes less frequent, eventually stopping altogether.

He noted that menopause was a state in womanhood when menstruation ceased, marking the end of the reproductive life of a woman.

“It means that the ovaries stop making hormones and periods stop at a younger age,’’ Igboeli said.

Igboeli explained that, “premature menopause is the loss of the functions of the ovaries before the age of 40 and it is mostly caused by primary ovarian failure.

“Due to certain health and genetic conditions, younger women have started experiencing menopause before their time.

“In cases where the mother experiences menopause early, the daughter is likely to also experience it when she reaches the age when her mother experienced it,’’ he said.

Igboeli disclosed that premature menopause could also be induced as a result of frequent treatments of certain diseases such as cancer.

The gynaecologist said that symptoms of menopause such as periods of feeling heat leading to excessive sweating, known as hot flashes, were common initial symptoms.

According to him, eating a healthy diet and exercising regularly could help manage menopause symptoms.

He added that physical symptoms include sleep disturbances, feeling of anxiety, irritability, experiencing difficulty in concentrating and depression.

“The woman may also experience wrinkling of the skin as well as sexual dysfunction, although these symptoms become brief after a while.’’

The gynaecologist said that hormone replacement therapy could be used for women who were experiencing severe cases of menopause.

He added that women who had gone through early menopause had the option of Assisted Reproductive Technique, a method used to achieve pregnancy by artificial or partial means.

“They are also hormones used in the therapy of early menopause known as dietary estrogens,’’ he said.

Igboeli, therefore, advised women who were experiencing early menopause to help themselves by improving on their diet and not to despair.

(NAN)

Towards Professional Excellence: The Role of the Academic Pharmacist

0
PCN Inducts 148 Unilag’s Pharmacy Graduands
A cross section of the Pharmacy graduands taking their oath.

By Adaobi Uchenna Mosanya

“Blacksmith, either do your job or get off the bench,” goes a Spanish adage. Anything worth doing is worth doing well. Professional excellence is to be extremely good at one’s job. It is not about how much but how well. A professional in any occupation is recognised by his excellence, which marks him out among his peers. Excellence is never an accident but attained in professional life over a long period. One cannot be an excellent academic pharmacist in one day.

Excellence is a habit, not an act. As the famous Philosopher, Aristotle said, “We are what we repeatedly do.” The path to professional excellence is an arduous one and many have fallen out because of its demands. Nevertheless, it is always important to strive for it.

Who is an academic pharmacist? A pharmacist in academia is one who is employed usually full-time in an educational institute, whose role involves teaching student pharmacists and engaging in scholarly work or research. They are also known as research-based academicians.

Pharmacy practitioners in other settings apart from the academic institutions can be adjunct academic pharmacists. These practice-based pharmacists are part-time faculty members who give lectures, as well as serve as mentors for the professional training of pharmacy students, especially in hospitals and community settings.

Some of the research areas for academic pharmacist are: drug discovery, manufacturing, and formulation, improvement in pharmacy practice, as well as enhancing therapeutic and health outcomes. The hours adding up to excellence are long but they are necessary to utilise available occasions for advancement and impact in society. Before advancing, one has to enter into the university, first as a lecturer, then become a senior lecturer, reader, and finally a professor. A pharmacist can be promoted in an academic career by acquiring international reputation and roles, especially in research (Hensley, 2017).

Pharmacists who desire to work with students, as well as carry out research are usually attracted to practice in academia. It inspires them to see young people interested in one’s profession. And for them, it is a privilege to prepare the next generation of pharmacists.

Apart from the already mentioned roles of pharmacists in academia, others are indispensable to achieve professional excellence. They include: publishing impactful papers in reputable peer-reviewed journals, attending and speaking at conferences, as well as volunteering to serve as external examiners and other service activities.

 

Path to excellence

A career in academia offers a high level of job security and opportunities for professional advancement. There is no excuse for failure to strive for excellence. To succeed, one should realise what the expectations are. For every profession, there are excellent standards. Some of the expectations for the academic pharmacist are: appropriate postgraduate education and training, board certification, commitment to a practice or research area, a good understanding of the evaluation and promotion processes, etc. The attributes of 7-star pharmacists apply as well to academic pharmacists. These are: compassionate caregiver, decision-maker, active communicator, lifelong learner, good manager, possesses good leadership qualities and can be a teacher and a researcher (Azhar et al., 2009)

Where there are no clear expectations, one can become anxious and confused (Rigoni & Nelson, 2016). A good grasp of the expectations enables one to define one’s expectations. Balancing expectations in teaching, research and service is crucial. These include seeking and finding a good, willing and senior faculty mentor, documentation of one’s achievements, seeking feedback and being open to criticism. It follows that the academician implements and tracks corrective measures early in his career.

 

Role of mentorship

A scholar can only become a good mentor in the future after struggling to be a good mentee as a young career fellow. One should avail oneself of the blended learning techniques. Striving for excellence means looking for how to improve. A mentee can learn from a mentor how to apply scientific knowledge in teaching, research or providing expertise, as well as the ability to solve problems. Decision-making and problem-solving skills are two sides of a coin. They lead to professionalism and prestige, which invariably bring about autonomy, another attractive characteristic of the career in academia. A sense of responsibility, self-discipline, and initiative come with autonomy. Without these traits, it is impossible to achieve professional excellence.

One can learn, besides, how to create new knowledge by conducting research and how to disseminate the results through appropriate media. Other skills that could be learnt from mentors are the ability to balance career and personal life. That is, to create time in one’s schedule for leisure, family obligations, social and religious responsibilities, and commitments. Achieving this balance prevents burnout.

Independence, self-motivation and collaborative spirit are what a good mentor should bring about in their mentees. Despotic and domineering as well as indulgent and spoon-feeding attitudes are two extremes to be avoided to bring about in a mentee a constant striving for professional excellence. Virtue is in the middle, according to the famous Saint Thomas Aquinas.  To find a good mentor is to find a treasure.

 

Flexibility and diversity

An attractive aspect of the work in academia is flexibility and a variety of activities. So, there is never a dull moment. In other words, the academician must embrace diversity to progress. With all these plethoras of activities and responsibilities, it invariably means that an academic pharmacist has to be multi-tasking. Multi-tasking does not mean biting more than one can chew; it means having a plan, a schedule for the multiple tasks to carry them out at the appropriate time and place.

Weekly calendar, noting what to do when to do and how is important to schedule. It means focusing on what one is doing at each point in time, without worrying about other pending or undone tasks. It does not mean fretting about and having several unfinished tasks; it means accomplishing each task very well to the last detail, adding the finishing touches which are a mark of excellence.

To succeed, one needs to be organised. An added trait to those who multi-task effectively is delegation. It is the ability to share jobs, to count on others and have a healthy form of dependence because nobody is a super being.

 

Innovative thinking and continuous development

As a researcher who seeks out new solutions for new problems while relying on previously useful solutions, innovative thinking is of utmost importance. Innovative solutions and thinking about pharmacy issues lead to new ideas in general pharmacy practice, as well as in the academic setting. It, therefore, means that academic pharmacists need to be in touch with their fellow pharmacists in practice field for synergy.

What does it profit a pharmacist in academia and the society at large, a research that is far removed from real-time? What good is research that has no relevance to the patient in today’s world? Networking and collaboration with colleagues in academia and practice/industrial teams help to prevent that kind of situation from occurring. Working in isolation is not acceptable. Openness to new ideas is crucial to evolve and grow. The need for both national and international teambuilding for an academic pharmacist can never be overemphasised.

Mediocrity is the fungus of the mind. It is also the sepulchre of excellence. An academic pharmacist who asks for his name to be included as an author of a manuscript without making any contribution to it is mediocre. And one who accepts to add such a name is worse off. The secret of joy in work is excellence, and knowing how to do something well is to enjoy it.

To build excellence in one’s chosen area(s), the academic pharmacist needs continuous professional development through workshops and seminars, enrolling in online courses, etc, because excellence is the unlimited ability to improve the quality of what one has to offer. After the learning process follows the application of the knowledge acquired, for example, effective use of technology in teaching, research writing skills, research conducting skills together with a good knowledge of statistical analysis.  Excellence is a way of life. Hard work and dedication are virtues necessary for a successful lifestyle.

Professional excellence is to be extremely good at one’s job. It is not the same as perfectionism. Perfectionism is focused on ‘doing the thing right’, on how things appear, and if others think it’s done right (Winn, 2013). While excellence is about ‘doing the right thing’. It is focused on the reason for the task and the results. Excellence is trying to do one’s best. Lecturers need to choose an area they are passionate about, to be creative when pitching. However, commitment is much more important.

 

Managing challenges

Academia is not an easy option for pharmacists. Some of the challenges are failure to get grants, or one’s research might not go as expected. However, successes are often.

An unappealing aspect of a career in academia is low salaries. Money should not be the most important factor in making a decision but rather future job satisfaction. Delayed gratification today for something great tomorrow is key. Nevertheless, funding is a necessity for achieving excellence. Undoubtedly, it is a challenge to find funding but one must not lose heart. Lecturers are expected to fundraise and form their research teams. They are usually promoted because of their fundraising and impactful research abilities.

Academicians should be able to seek legitimate outside sources of income (e.g. through consulting projects) to supplement their faculty salary. They can set up spin-off companies related to their work. Applying and getting grants, as well as winning awards can make pharmacists stand out among their peers. Launching a related business helps to take care of the economic responsibilities needed to successfully conclude the research.

For this to be a reality, they need to collaborate initially with people who complement their skills and have the same goals. Besides, it pays to do so with people with a good reputation.  Patience is an important virtue to succeed in academia because the impact of research might need many years before it is palpable.

Kurt Tucholsky once said, “The will to win, the desire to succeed and the urge to reach your potentials will unlock the door to personal excellence.” These words can be used as keys by academic pharmacists who wish to unlock the door to professional excellence. On their path towards professional excellence, academic pharmacists will have ups and downs. It is a path of roses with thorns. It is expected that they acquire the ability to handle with equanimity both failures and successes.

Failures should be considered as a spur to aim higher. Failures are not the end of the world, although they are experienced as setbacks. As a famous scientist, Thomas Edison in his experiments exclaimed after 999 failures that he had succeeded in eliminating 999 ways of not inventing the electric bulb. It is human to make mistakes, and such should be understood as part of the learning process.

The great scientists and thinkers that ever existed since the beginning of mankind made mistakes. One distinguishing mark of all is the ability to learn, thereby adding to the existing knowledge.  This led to the mastering of their work which is the foundation of lasting self-confidence and self-esteem.

 

Handling leadership and interpersonal relationships

It has also been recognised that one of the least appealing aspects of the career of a pharmacist in academia is management and administration. However, readiness to take up, at the right time, some managerial roles as dean, department head, exam officers, etc is necessary. Therefore, it is required that we invest adequate resources in developing our inherent leadership potentials.

Workloads can be heavy but we cannot shy away from greater responsibilities. As the saying goes, the reward for good work is more work. But it is equally healthy to know when to say “yes” or “no”.

To enjoy all the roles of an academician and carry them out effectively, self-management skills are needed. Leadership begins with the leadership of oneself, which is called self-leadership, personal effectiveness or self-management. One cannot give what one does not have, it is as simple as that. What can we make of a leader who is not punctual, for instance, to meetings?

Self-discipline is paramount to teach with authority through one’s lifestyle. What about emotional intelligence? This is often a neglected but important aspect of personality development. How we handle our emotions and other people’s emotions is essential.

Interpersonal relationships are fundamental in academia. No man is an island. The professional ambiance found in academic institutions demands its etiquette. In such an environment, there is always an established hierarchy that ought to be respected and fostered. There is also a diversity of persons from different backgrounds and cultures. Cultural awareness or sensitivity is the first step towards cultural competency. It is the recognition that differences between cultures exist and are based on many factors, including religion, race, ethnicity, gender, education, nationality, politics and geographic origin (Matsumoto, 2007; Alsharif et al., 2019).

We cannot afford to overlook certain social etiquette, which simply means, consideration for the other person. Consideration in terms of beliefs, preferences, position, etc. Professional ethics are equally important. It is defined as the personal and corporate rules that govern behaviour within the context of a particular profession. Lack of familiarity with the principles of ethics in this noble profession can cause irreparable damage to the career ambitions of the person involved as well as to the society (Kholghipour et al., 2018).

In conclusion, the assurance that pharmacists are competent falls at the feet of educators and the public’s health is better off. They are perceived as prestigious members of the community. It flows as a natural consequence that if academic pharmacists strive for excellence, then they will produce competent pharmacists in various fields of practice. Public health also could be better ensured by expecting a better working relationship between the agencies and academic institutions through improvements to advisory committee recruitment.

 

Bibliography

Alsharif, N. Z., Brennan, L., Abrons, J. P., & Chahine, E. B. (2019). Introduction to cultural sensitivity and global pharmacy engagement. Journal of Pharmaceutical Education, 83 (4) Article 7221.

Azhar, S., Hassali, M. A., Izham, M., Ibrahim, M., Ahmad, M., Masood, I., & Shafie, A. A. (2009). Human Resources for Health The role of pharmacists in developing countries : the current scenario in Pakistan. 6, 1–6. https://doi.org/10.1186/1478-4491-7-54

Hensley, S. (2017). The role of academic pharmacists in science and research. The pharmaceutical journal, 298 Article 7898, online. DOI: 10.1211/PJ.2017.20202159

Kholghipour, H., Dehshahri, A., Mahmoudian, H., & Nabeici, P. (2018). Shiraz pharmaceutical students’ knowledge about pharmacy professional ethics. Journal of Medical Education, 17 (3): 168-174Matsumoto D. (2007). Culture, context and behaviour. J. Personality, 75(6):1285-1319

Rigoni, B., & Nelson, B. (2016). “Do employees really know what’s expected of them?” Gallup Business Journal, https://news.gallup.com/businessjournal/195803/employees-really-know-expected.aspx.

Winn, M. (2013) Perfectionism Vs Excellence. Available at http://theviewinside.me/perfectionism-vs-excellence/ accessed March 14, 2020

Adaobi Uchenna Mosanya wrote from the Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences. University of Nigeria, Nsukka, PMB 410001, Enugu State. adaobi.mosanya@unn.edu.ng Telephone: +234 8054570666

https://orcid.org/0000-0002-8442-4358

Shun Drug Abuse, NDLEA Boss Tells Youth

0

 

Shun Drug Abuse, NDLEA tells youth

Mrs Archie-Abia Ibinabo, Commander, Idiroko Borderland Special Area Command of the National Drug Law Enforcement Agency, has cautioned youths against drug abuse, charging them to live a meaningful life.

Ibinabo lamented that there was so much disconnect in the society, noting that there was a need to go back to the old method of engaging the youths in the system ‘’because they are the generation we are living now.’’

She admonished the youths to shun abuse of drugs and illicit drug trafficking and to channel their energies toward profitable engagements to fulfill their dreams.

According to her, abuse of drugs will lead to addiction and the destruction of their dreams.

She, however, called for concerted efforts to engage the youths in different skills and create employment opportunities for them to be able to withstand the pressure.

Ibinabo lamented that there was so much disconnect in the society, noting that there was a need to go back to the old method of engaging the youths in the system ‘’because they are the generation we are living now.’’

“On our part, we have started a football club in Idiroko axis so that we can bring the youths out of the streets and channel their energies towards profitable engagement.

“We should be determined to involve them as this would make them have a sense of belonging and prevent them from going into crime,” she said.

(NAN)

How Evidence-Based Engagement is Transforming Brand Growth in Nigeria

0

 

Emily E. Ezekwu

In Nigeria’s evolving pharmaceutical industry, the shift toward data-driven marketing and evidence-based field engagement has redefined how companies communicate with healthcare providers. Long before analytics became a standard expectation across global life-science markets, Nigerian professionals were already shaping sophisticated, insight-driven marketing techniques to improve provider education and strengthen brand competitiveness. Among those at the forefront of this transformation is Emily E. Ezekwu, a pharmacist and medical sales professional whose contributions helped reshape commercial operations across Nigeria’s Northwest region

Ezekwu’s work demonstrated a forward-thinking integration of data analytics into field-force strategy at a time when many pharmaceutical teams still relied primarily on traditional detailing. Her evidence-based engagement methods provided physicians with clarity, relevance, and improved access to emerging clinical information. These approaches not only enhanced therapeutic adoption but also delivered measurable commercial outcomes across critical therapeutic areas.

Industry observers note that Ezekwu’s early adoption of structured data feedback mechanisms placed her several years ahead of mainstream pharmaceutical marketing practices in Nigeria.

Reshaping Field-Force Engagement through Data Analytics

During her years as a Medical Sales Representative and later as a Medical Sales Liaison at Novartis, Ezekwu implemented structured customer-analysis practices that improved message alignment and informed strategic planning. Her approach centred on understanding physician needs through quantifiable insights rather than assumptions. By analysing prescriber behaviour, engagement frequencies, and regional adoption patterns, she helped refine field-force deployment ensuring that medical representatives prioritised high-impact clinical discussions over generic promotional messaging.

These analytics-driven improvements contributed to repeated high performance in the region, including the achievement of above 80 percent sales-to-target for several consecutive years and significant revenue growth for fast-moving cardio-renal brands.

Real-Time Feedback Tools for Precision Physician Education

A core element of Ezekwu’s contribution was her use of real-time feedback tools to strengthen physician engagement. These tools allowed her teams to assess brand perception, identify knowledge gaps, and capture frontline insights during clinical discussions. With these real-time questionnaires and rapid feedback loops, educational content was updated swiftly and tailored to specialist needs.

This level of responsiveness enhanced physician confidence in the therapies promoted and helped translate clinical evidence into practical prescribing decisions. It also enabled Emily and her colleagues to correct misconceptions proactively and address treatment-related uncertainties in fast-moving therapeutic landscapes.

Her ability to integrate real-time learning into market engagement was widely viewed as an innovative enhancement to conventional detailing models.

Leadership Lessons from High-Performing Northwest Teams

Ezekwu played a notable leadership role in strengthening regional teamwork and field representation. Her work involved guiding newly onboarded personnel, reducing turnover by reinforcing analytical skills, and promoting operational excellence across the Northwest region. Under her influence, the regional team consistently ranked among the highest-performing medical field units in the company.

Ezekwu’s leadership principles were grounded in discipline, evidence-driven decision-making, and an emphasis on continuous learning. She championed collaborative problem-solving and encouraged representatives to rely on measurable indicators rather than routine assumptions to refine their interactions with healthcare providers.

Her contributions did not go unnoticed. She earned multiple performance recognitions, including regional awards for surpassing commercial objectives and optimising brand performance through structured stock monitoring and customer support systems

Sustaining Market-Share Growth through Best Practices

Ezekwu’s record offers a clear blueprint for sustained market influence in Nigeria’s competitive pharmaceutical environment. Her best practices included: Demand-forecasting analytics to reduce stockouts and improve product availability; Weekly engagement dashboards to track physician interactions and guide strategic adjustments.

Others are structured messaging frameworks aligned with evolving clinical evidence; Customer-segmented outreach that prioritised high-yield therapeutic clusters: and Cross-functional coordination to ensure unified field-force messaging and operational clarity.

These strategies helped maintain a high share of voice in key therapeutic areas and strengthened brand awareness across major specialist groups.

Experts in pharmaceutical commercialization note that such structured, analytics-based practices remain essential in building resilient brand strategies particularly in diverse and expanding markets like Nigeria.

A Lasting Contribution to Nigeria’s Evolving Pharmaceutical Landscape

Ezekwu’s work stands as a powerful example of how data-driven marketing can uplift pharmaceutical operations, strengthen physician engagement, and contribute positively to public health outcomes. By merging clinical knowledge with analytical precision, she helped catalyse a more mature, evidence-grounded approach to pharmaceutical field strategy in Nigeria.

Her achievements continue to serve as a model for marketing teams seeking to navigate increasingly complex therapeutic markets with clarity, innovation, and measurable impact.

 

 

Old Techniques Preventing Inclusion of New Trends in Pharmacy Curriculum- President, PANS-ABU

0
Old Techniques Preventing Inclusion of New Trends in Pharmacy Curriculum- President, PANS-ABU
Adam Abdulraheem

 

It was Steve Jobs who once opined that to make a meaningful impact in the world, “you have to be burning with an idea, or a problem, or a wrong that you want to right.”  For Adam Abdulraheem, popularly known as PharmaCopious, a 500 Level Pharmacy student and president of the Pharmaceutical Association of Nigeria Students (PANS), Ahmadu Bello University (ABU), Zaria, Kaduna State, what drives his passion, is the desire to be a public healthcare provider and ultimately join national politics so as to serve the less privileged in the society. In this interview with ADEBAYO OLADEJO, the young scholar who was born and brought in Zaria, highlights the peculiarities of studying Pharmacy in the northern part of the country, as well as the achievements and plans of his administration. Excerpts:

Why Pharmacy, out of several other health-related courses you could have studied at the university?

My drive to prefer Pharmacy is its multidisciplinary nature. Despite Pharmacy being a tedious course of study at the university, it is still the most loved, luxurious, satisfying and most versatile profession in the healthcare space. It is only a pharmacist that produces a product and also renders a service, the medical doctor only offers service and so do the nurses and other members of the healthcare team.

How did you become PANS-ABU president?

The journey started towards the end of my 300 Level days, as a result of advice from my friends and different members of the faculty to contest for the office of financial secretary, which was my first official role. I worked with the then president, Pharm. Suleiman Muhammad Gidado, and his successor, Sen. Huzaifah Ahmad Muhammad, as financial secretary and secretary-general respectively.

I gathered exuberant experience from the administrations and that forms the basis for my aspiration to contest for presidency. The trust that PANSites had in me was what motivated me to run for the post of president.

It can be tough combining studies with active involvement in other activities, how have you been coping?

It’s very tough and rough, but I plan my activities. I attend most lectures and practicals but use most of my nighttime to plan ahead. I know myself, so I usually read a day or even a night to an examination or test. Despite the hardship, being in the forefront and as a voice and representative of entire students of the faculty, I have to work the extra mile to ensure the stability of both the academics and leadership.

That’s the beginning of the future; one must surely be a leader someday, today or tomorrow. For me, it has started and the experience is becoming an inspiration to do more and soar higher.

What achievements have you recorded and what challenges have you encountered so far?

So far so good, I have achieved a lot from the inception of my administration to date. The most important of this is rendering support to PANSites in need of moral, academic and financial support. With support from our patrons and mentors, I have been able to complete 50 per cent of my agenda within the first quarter of my administration, though most of them have not been launched due to the halt in academic activities. Immediately after resumption, the projects shall be a surprise to all.

The few I can mention here are free registration support for newly admitted students where we make all necessary uploads, photocopy and printing of documents; editorial publications; bringing the first-ever PANS e-library to the limelight; refurbishing the Pharmacy Garden; provision of teaching and learning aids to classes; financial aids to students to enable them to pay school fees; and many more academic and welfare interventions.

We are still not relenting during the strike as an online poetry competition was hosted and the winners were awarded cash prizes.

Are there challenges associated with studying Pharmacy in the north, compared to the south?

Yes, of course. Pharmaceutical firms are abundant in the south and that gives the students more opportunity to explore different aspects of the profession with ease, most especially Industrial Pharmacy aspects. Here in the north, we don’t have industrial settlements and that limits the experience graduates get in the industry – unlike the south which has abundant industries to venture into during SIWES, sessional breaks and others.

Some years back, internship placement was far easy to secure in the north than in the south, due to the limited number of pharmacy schools and abundant internship centres in the north, compared to the south; but now it is very difficult. Some people spend two or three years of post-graduation before getting to start their internship.

 

The scandal of “sex-for-marks” has recently become a significant issue in universities, especially in public schools. How would you react to this, using the Faculty of Pharmaceutical Sciences, ABU?

I don’t know how to react to this, because it does not in any way affect the Faculty of Pharmaceutical Sciences, ABU, Zaria. I hear about that only in the news, but it has nothing to do with my school. Pharmacy students are known to be talented go-getters and hardworking students within the university and beyond.

 

If you had the honour of changing some things about pharmacy education in ABU, what would they be?

Firstly, the curriculum; technology is advancing each and every day and so also should our curriculum. Many old techniques are now extinct but are still part of the curriculum while new technologies that are available now have no space to get accommodated. Reviewing the curriculum will clear a lot of debris and create room for advancement.

Secondly, the introduction of summer semester or resit examinations because students may fail tests and examinations due to reasons beyond human control, like health and mental reasons. Aside from that, many people spill over because of one or two courses. The introduction of this summer semester or resit examination will bring an end to this kind of issue.

Finally, infrastructural development, which is also as paramount as any of the earlier stated, involves upgrading the laboratories, libraries, lecture halls and pharmacy students’ accommodation to global standards, in order to compete with any pharmacy school in the world.

When you finish from pharmacy school, which area of pharmacy practice would you consider and why?

Public health pharmacy and the reason is to serve the world by ensuring healthcare for all and bringing in policies that will positively affect the health status of the world. I have a keen interest in community pharmacy, but it encompasses a specific population; while public health pharmacy is vast and encompasses the world, especially the rural areas and the less privileged. Also if conditions warrant, I will join politics.

 

Where do you see PANS-ABU by the time you will be leaving office?

PANS-ABU will be at an enviable height by the end of my administration – becoming an association doing well to serve its members and protect their interests. The PANS of my dream is that which will have the ability to cater for all her members’ need. It will be another great milestone; a bigger picture, which portrays the core values, dedication and honesty.

Transformation Starts with Inspirational Leadership (2)

0

The Journey of Agile Organisation

Habits of Highly Productive Transformation Leaders
Prof. Lere Baale

 

(Continued from last edition)

Inspiration in a DVUCARD world

Every organisation needs to move with the times. The world we live and work in today is constantly evolving, reshaping and changing. We are in the grip of a digital technological revolution that makes the rate of change exponential. The consequence of this growth is that the environment we work in every day is fragile, often faced with Disruption, Volatility, Uncertainty, Chaos, Ambiguity, Risks and Diversity (DVUCARD).

The initial term VUCA comes from the US Military’s approach to military operations. The military recognises that the world we operate in is volatile, uncertain, complex and ambiguous, and trains its leaders to lead and command in this environment. The world of business has similar parallels courtesy of the COVID-19 pandemic.

  • Is your business Disrupted?

Is your business Volatile and constantly changing?

  • Do you face Uncertainty in your daily work?
  • Is your business operation becoming Chaotic and complex?
  • Do your leaders need to understand how to perform and deal with Ambiguity?

Is your business becoming increasingly Riskier?

Is your organisation becoming more Diverse in personalities, ethnicity, religion, and gender, among others?

If this resonates with you, then inspirational leadership will add value to your business world.

Striking a good balance

Today’s leaders face the daily challenge of navigating this chaotic complex world and leading their followers to successful outcomes. Bouncy waves of employees join companies every day and expect to see rapid career progression. We live in a world that expects instant results. People know the path to life improvement as earning more money, and the route to this is to climb the corporate ladder and gain promotion and a higher wage.

If this progression is too fast, disaster can strike. The leader has no idea what to do, acts with poor leadership skills and cannot inspire their followers. This is summed up in the “Leader Poem” by Roger McGough:

I want to be a leader.

I want to be a leader.

Can I be the leader?

Can I? Can I?

Promise? Promise?

Yippee, I am the leader

I am the leader

OK, what shall we do?

 

The follower becomes the leader, but they do not know how to lead, let alone be an inspirational leader. This is when inward reflection, combined with education on leadership and understanding of “inspiration”, is needed.

But what causes us to become “inspired”, and what motivates us to act on this inspiration? How do we become inspirational leaders?

Let us explore these questions.

The essence of inspirational leadership

Any form of leadership that inspires a person to act either directly or through empowerment for the benefit of others and an organisation is inspirational leadership. For action to take place, certain conditions must exist in interpersonal relationships. Two critical factors for success are mutual trust and the ability of a leader to inspire others.

Leaders have a moral obligation to provide guidance, mentoring, coaching and resources to their teams. A leader should seek to empower their teams and create the conditions for individuals to use their initiative and judgement in their work. In return, followers must act with loyalty and discipline.

Mutual trust is needed. Trust is a two-way process; whether leader or led, it is created by living our values to professional standards and setting an appropriate example.

Steven Covey describes trust as a mixture of character and competence. Character is a combination of integrity and intent. The character can be developed and enhanced once leaders understand the importance of authenticity in leadership and revealing vulnerabilities.

Leaders also need to understand the importance of behaviours in role modelling and learn valuable techniques, such as storytelling to enhance engagement skills. This will build character.

The intent is more challenging to develop. This is guided by individual motivation and drivers, and can easily be detected by followers. Intent affects the impact of leaders and their inspirational capability. Development programmes, which include coaching, can help leaders reflect on their purpose and understand their impact on others.

This interaction (visible and invisible) between leaders and followers is essential and affects the relationship and trust in teams, which in turn affects the environment necessary for inspiration to flourish.

An inspirational leader is a role model guided by a set of morally good core values. They behave in a way aligned with the organisation’s values and conduct their work in a responsible and accountable manner. Such leaders constantly work to improve their leadership skills and deliver high-performance standards. They are authentic leaders who “walk the talk” and inspire others to follow and raise their performance to achieve more significant outcomes.

Inspirational leadership should be considered a leadership ethos that creates a climate where teams and individuals flourish. The climate people work in stimulates aligned action towards successful outcomes, people feel empowered, teaming is visible, enthusiasm is present, and individuals are committed to the organisation’s success.

Inspirational leadership – impact on organisation climate, performance and maturity

Organisational culture is the overall organisational values, norms and beliefs that shape an organisation. An organisation’s culture should be thought of as the atmosphere; the climate of an organisation is the more localised version of culture. The temperature should be considered the local “weather” people experience at a given time.

Inspirational leadership directly impacts the climate of a team or localised organisation. Lots of mixed climates, in turn, impact the culture and, consequently, organisational performance. If leaders create positive and engaging work climates, they build a positive, innovative culture.

These positive climates can create a movement that will create enough momentum for an organisation to evolve, change, and transform at a certain tipping point. Local positive climates encourage teams to perform to higher levels. These climates, in turn, have an impact on the success of an organisation.

However, no leader works in isolation. Both good and bad leadership directly impacts the climate and culture of an organisation and its maturity. However, what does a mature organisation look like?

 

Teal leadership

Over the years, many academics have developed organisation maturity models. Frederic Laloux developed one such model in his publication, Reinventing Organisations. From our experience, we believe that the “Teal” organisation is the highest level of organisational maturity. Leaders who seek to build positive climates will generate enough momentum to help organisations move to a “Teal” story.

We believe that inspirational leadership is critical to reaching the “Teal” level of maturity. We propose that this level is reached when inspirational leaders establish a good team climate, teams link up, and inspiration and innovation spread, creating an innovative organisational culture. These are the four levels of organisational maturity, namely Teal, Green, Orange and Red:

Teal: Evolutionary, purpose-driven.

Focuses on inner integrity and sees systemically

Dis-identifies with own ego

purpose-driven

radical authenticity

inner rightness as a compass

 

Green: Pluralistic, relationship-driven.

Focus on fairness, community and equality of all perspectives

Justice for all

consensus

relationship over outcomes

empowerment

values-driven culture

multi-stakeholder perspective

 

Orange: Achievement, results-driven

Focus on pragmatic, success-oriented and complex logic

Questions authority

get ahead

values freedom & achievement

innovation

accountability

meritocracy

 

Red: Conformist, role-driven

Focus on awareness of social roles and the following authority

Absolute truth (black and white)

can see other’s expectations

dogmatic long-term perspective

consistent process

size and stability (hierarchy)

 

What level of maturity do you think your organisation is currently at?

Where would you like to be?

Kaduna Committed to Registering Poor Residents, Vulnerable Households –Official

0

 

Kaduna Committed to Registering Poor Residents, Vulnerable Households –Official
Gov. Nasir El Rufai

The Kaduna State Operations Coordinating Unit says it is on track to capture all poor and vulnerable households across communities into the State Social Register.

The Coordinator of KADSCU, Mrs Nina Yakwal, stated this in Kaduna on Thursday at a two-day refresher training on Community-Based Targeting Process for the population of the state social register.

The News Agency of Nigeria reports that the training was organised for Desk Officers, Community-Based Targeting teams, and Grievance Redress Officers.

Yakwal said that the move was part of efforts to ensure quality community sensitisation, mobilisation, engagement and enumeration of poor and vulnerable households in every community of the state.

She said that so far, communities in Kaduna North Local Government Area, Ikara, Kubau, and other areas have been saturated and captured into the social register.

She added that “we are hoping that by the end of the refresher training, all the CBT teams and enumerators will develop a work plan to cover all unsaturated communities in the state.

“This will enable us to develop a holistic database of all poor and vulnerable in the state for evidence-based planning,” she said.

She said that a total of 494 Desk Officers, Community-Based Targeting teams, Grievance Redress Officers, and other officials across the three Senatorial Zones in the state were participating in the refresher training.

She explained that 165 officials of Kaduna North Senatorial District had been trained, 160 from Kaduna Central Senatorial District currently undergoing the training, while a total of 169 officials would be trained in Kaduna South Senatorial District.

Earlier, the KADSOCU Head of Operations, Mr. Biya Dogon said that a total of 680,888 poor and vulnerable households amounting to 2.6 million individuals have been captured into the social register.

Dogon maintained that the objective of the training was to provide a better understanding of the CBT process and progress so far in populating the social register.

He said that the training also created an avenue to share experiences, and lessons learnt and get feedback from all stakeholders on ways forward.

He added that the capacity building would promote clean and relevant data generation for evidence-based planning and decision-making in the state and for effective utilisation by interested organisations.

Mr. Bityong Isah, Managing Information System II, KADSOCU, urged the officials to be diligent in the CBT process to ensure quality data generation for the register.

According to him, anything less than the expected standard would be rejected and might discourage stakeholders from using the register to select beneficiaries for social protection intervention.

Mrs. Saude Atoyebi, the Focal Person, Kaduna State Social Investment Office, commended the CTB teams, the enumerators and the grievance redress office for their selfless services to humanity.

Atoyebi, who was represented by Mrs. Rebecca Padonu, Special Assistant to Governor Nasir El-Rufai on Social Investment, urged the officials to support the development of a credible social register in the state.

Mrs. Jessica Bartholomew, the Chairperson of the Kaduna Social Protection Accountability Coalition, urged the officials to continue to work with social protection champions in the local government areas who would be monitoring the CBT process.

(NAN)

FIP Urges Pharmacists to Expand Roles in Mental Health

0

– Releases New Guidelines on Mental Health

NGO Launches Toll-Free Hotline for Assistance on Mental Health
Mental health

 

The International Pharmaceutical Federation (FIP) has admonished pharmacists across the globe to expand roles in mental health, with recommendation of two new guidelines .

In a press statement from the FIP, made available to Pharmanewsonline, the Chairman, FIP Board of Pharmaceutical Practice, Mr Paul Sinclair said, “It is estimated that 7% of all global burden of disease and 19% of all years lived with disability are attributable to mental and addictive disorders.

“We know that the COVID-19 pandemic has increased the incidence of mental illness and reduced availability of mental health services, but there was already a massive deficiency in mental health care that needed to be resolved in many countries before the pandemic. We know that pharmacists can play a significant part in addressing these shortages and make a big difference to improving global health in this way”.

He mentioned the two new guidelines as : “Mental healthcare — A handbook for pharmacists”; and “Knowledge and skills reference guide for professional development in mental health care”.

Sinclair explained that the two new guidelines were developed in collaboration with an international group of experts with the sole aim of supporting and creating awareness of the importance of pharmacy practice, and presenting the many potential mental healthcare actions that pharmacists can perform, from preventing mental illness and screening for signs to optimising medication and responding to mental health crises.

To ratify his previous claim, Mr Sinclair further stated that, “It is vital that we expand the health workforce that can flag mental health issues, provide mental health first aid, refer people with lived-experience of mental illness to specialists and provide subsequent support. Pharmacists’ accessibility and positive relationships with people in their communities can be utilised. They can be and need to be engaged in mental health, and these two new FIP resources supports them to do so”.

The keynote observed and affirmed is that the reference guide is intended to accompany the handbook and define the knowledge and skills that pharmacists need to acquire to provide mental healthcare and other related services.

 

 

 

 

Sanwo-Olu Suspends Lawful Abortion Guidelines

0

 

Africa Records More Deaths from Unsafe Abortions –WHO
A premature baby

Sequel to the public outcry trailing the newly launched safe and lawful abortion guidelines by the Lagos State Ministry of Health, Governor Babajide Sanwo-Olu has directed the suspension of the implementation to allow more time for public sensitization and enlightenment.

The Lagos State Commissioner for Health, Prof. Akin Abayomi, made the announcement on Thursday through a statement issued from his office and signed by him.

Recall Pharmanewsonline published the release of the safe abortion guidelines tagged “Lagos State Guidelines on Safe Termination of Pregnancy for Legal Indications”, recently, as presented at a stakeholders’ engagement forum by the Lagos Ministry of Health.

Abayomi explained rationale behind the initial release of the policy, which he said was to reduce maternal mortality and eliminate illegal abortions. Thus the ministry engaged experts in Law and in Obstetrics and Gynaecology with a focus to reducing maternal deaths.

According to him: “Lagos State Governor Babajide Sanwo-Olu has directed the suspension of the “State Guidelines on Safe Termination of Pregnancy for Legal Indications” issued by the Directorate of Family Health and Nutrition in the Ministry of Health”,  the statement reads:

“Among the several factors that contribute to maternal mortality, illegal abortions and high risk pregnancies leading to unresolvable complications rank high.

“The Lagos State Ministry of Health is seeking different methods to eliminate illegal abortions and ensure that a mother does not die at childbirth, thereby disrupting an entire family unit.

“In this regard, it became imperative to examine, in keeping with existing National and State laws and policies, if there are indeed justifications and medical reasons to offer abortion to a woman whose life is threatened by a pregnancy.

“Following this, the guideline was developed over four years through painstaking work by experts in Law and in Obstetrics and Gynaecology with a focus on creating the opportunity to reduce maternal mortality and in line with existing laws.

“These guidelines have generated immense public interest which has necessitated escalating it to Mr Governor, who has advised further sensitization of the public and key stakeholders to ensure a clearer understanding of the objectives of the guidelines.

“To this end, we are suspending the implementation of these guidelines in the meantime for the Executive Council to deliberate on this matter and ensure adequate public sensitization and stakeholder engagement to reach a consensus required for a successful guideline development.

“The Lagos State Ministry of Health remains committed to planning , devising and implementing policies that promote qualitative, affordable, and equitable healthcare services to the citizenry”.

Stakeholders Urge Improvement in Death Notification, Registration

0

Stakeholders urge improvement in death notification, registration

Stakeholders in the health and security sectors have called for improvement in death notification and registration in Nigeria.

They made the call on Wednesday in Lagos at a one-day symposium organised by the Nigeria Police Force Pathology Office in collaboration with the National Population Commission.

They noted that while many Nigerians registered births, not many registered deaths, even after obtaining death certificates before burial.

They expressed the belief that good data on births and deaths would help for proper national planning.

In his contribution, the Inspector-General of Police, Mr. Usman Baba, said the symposium was to sensitise the people of Lagos State on the need to increase death notification and registration.

Baba, who was represented by the Force Medical Officer, AIG Olubunmi Ogunsanwo, said that the Lagos State experience would spread the news to other states of the federation.

He said the two agencies decided to start the sensitisation from Lagos State because of its strategic position in the country.

He explained that donors of the grant for the hosting of the programme specifically requested that Lagos State be a starting point.

“Lagos as a state has led on so many fronts; when you look at the management of COVID-19 and Ebola, the state has robust structures. That is why we are starting here so that we can synergies,’’ he stressed.

The I-GP said that because of the event, the police would henceforth report the death of suspects in their custody to the NPC in line with legal protocols.

In his remarks, the NPC Chairman, Mr. Nasir Kwara, said that death notification and registration were very poor in all states of the federation, stressing the need for all to be sensitised on the issue.

Kwara was represented by Dr. Dayo Layide, Director, Health and Planning, Research, and Statistics of the NPC.

He called on the military, the police, para-military agencies, and religious and traditional leaders to sensitise their followers on the need for notification and registration of death.

He noted that the NPC had about 4,000 registration centres at government health centres in all states, stressing that birth was recording about 50 per cent registration annually, while death only recorded 10 per cent.

The Force Pathologist, Dr. Samuel Keshinro, said that there was a need for adequate sensitisation of the populace about death notification and registration through informants.

Keshinro said that apart from the medical doctors, any citizen from 18 years and above could notify and register the death of any relation, friend, or associate.

He said the information needed by the NPC in the event of death included the number of those who died and their identity.

He added that other information required was the cause of death to show the disease responsible and where the death occurred, to show environmental link.

He said about 5,922 deaths were registered in Lagos State in 2021, representing about four per cent of expected death registration (using the World Bank’s crude death rate calculations).

In his remarks, Force spokesman, CSP Olumuyiwa Adejobi, said the Nigeria Police Force was harmonising its database with the NPC, the FRSC, and the National Identity Management Commission in the six geo-political zones.

Adejobi said that harmonisation became necessary because of security challenges, stressing that such a central database would help for forensic investigation by all agencies.

The News Agency of Nigeria reports that participants at the symposium were drawn from the police, military, para-military agencies, medical, paramedical, religious, and traditional institutions.

It had “Increasing Death Notification and Registration in Lagos State’’ as its theme.

COVID-19 Cases Increased Nearly 30% in Two Weeks, Says WHO

0
COVID-19 cases increased nearly 30% in two weeks, says WHO
World Health Organisation

The World Health Organisation says the globally reported cases of COVID-19 have increased by nearly 30 per cent over the past two weeks.

WHO Director-General, Dr. Tedros Ghebreyesus, said this on Wednesday during an online COVID-19 media briefing.

Ghebreyesus said that four out of six of the WHO sub-regions saw cases increasing in the last week.

“In Europe and America, BA.4 and BA.5 are driving waves.

“In countries like India, a new sub-lineage of BA.2.75 has also been detected, which we’re following,’’ he said.

According to him, compounding the challenge are many factors.

Ghebreyesus said the first was that testing has reduced dramatically in many countries.

He said it obscures the true picture of an evolving virus and the real burden of COVID-19 disease globally.

The director said it also meant that treatments are not given early enough to prevent serious illness and or death.

“Second, new treatments, especially promising new oral antivirals, are still not reaching low and low-middle income countries, depriving whole populations that need them.

“Third, as the virus evolves, vaccine protection while still really effective at preventing serious disease and death does wane.

“Decreasing immunity underscores the importance of boosters, especially for the most at-risk.

“Fourth, each wave of the virus leaves more people with the long-COVID or post-COVID condition,’’ he said.

According to Ghebreyesus, it obviously impacts individuals and their families but it also puts an extra burden on health systems, the wider economy, and society-at-large.

He said the challenges required action at a global, national and local level.

He said that governments, scientists, manufacturers, WHO, and citizens themselves all have their part to play

According to him, essential steps to take include, vaccinating and boosting those at most risk.

Ghebreyesus said such included older people, people with chronic illnesses, the immunocompromised, and health workers noting that such steps will then help build up the wall of immunity throughout the population.

He said the second was to make new oral antivirals and other treatments available to all.

The director said that working with Global Fund and UNICEF, WHO developed an allocation mechanism to support countries as antivirals become available.

“So far, 20 countries have accepted allocations of Molnupiravir, which has moved into distribution.

“For Nirmatrelvir-Ritonavir, – or Paxlovid – 43 countries have expressed interest.

“However, our organisations are still trying to finalise with Pfizer the appropriate terms and conditions for low- and middle-income countries,’’ he said

According to him, this is delaying access and some countries may choose to wait for a generic version of the antiviral, probably available only in early 2023 and this will cost lives.

“I call on Pfizer to work closely with health agencies and countries to ensure its new oral antiviral is available quickly and effectively,’’ he said.

Ghebreyesus said the third was especially if you’re in a place where cases are on the rise, use tried and tested public health measures to mitigate risk.

“For example, if you’re in a crowded place or inside and there’s poor ventilation, put on a mask. And if you’re sick, and you can, stay home.”

The fourth, he said, was crucial to accelerate research and development into the next generation vaccines, tests, and treatments.

“WHO is working with scientists and researchers around the world to make this happen.

“Through the Solidarity Trials, WHO can ensure maximum efficiency of clinical trials so that new tools are developed quicker.

“We don’t know what the next variant will be like.

“This requires that we apply the tools we have now and that we develop the next generation of countermeasures quickly,’’ he said.

The WHO boss said the fifth was to continue to work to strengthen the global health architecture for health emergencies and response at all levels.

According to him, the organisation welcomes the news about the creation of the financial intermediary fund (FIF), which will focus on strengthening pandemic prevention, preparedness, and response capacities.

He said the organisation would operate at a national, regional, and global level, with a focus on low- and middle-income countries.

“WHO and the World Bank will take the design forward with the founding donors and broader stakeholders.

“We hope the fund will expand and that this will become an important component of a comprehensive financing solution for health emergencies.

Also, the pandemic accord process must continue at a pace.

This remains a generational opportunity to improve how countries prepare for and respond to new pathogens,’’ he said.

On monkeypox, the boss said the organisation has continued to be concerned by the scale and spread of the virus.

According to him, across the world, there has now been more than 6000 cases recorded in 58 countries.

“Testing remains a challenge and there are probably a significant number of cases not being picked up.

“Europe is the current epicentre of the outbreak, recording more than 80 per cent of cases globally.

“In Africa, cases are appearing in countries not previously affected and record numbers are being recorded in places which have previous experience with monkeypox.

He said his teams were following the data closely as he planned to reconvene the emergency committee so they are updated on the current epidemiology and evolution of the outbreak and implementation of countermeasures.

“I will bring them together during the week of 18 July or sooner if needed.

“WHO is working with countries and vaccine manufacturers to coordinate the sharing of vaccines, which are currently scarce and need to be accessible to the most at-risk people.

“WHO is also working closely with civil society and LGBTIQ+ community, especially to break the stigma around the virus and spread information so people can protect themselves,’’ Ghebreyesus said.

“I want to particularly commend those that are sharing videos online via social media channels talking about their symptoms and experiences with monkeypox.

“This is a positive way to break down the stigma about a virus that can affect anyone, the boss said.

Ghebreyesus said that in Syria, the humanitarian needs are at their highest level since the war started 11 years ago.

According to him, WHO works across the country to provide lifesaving health support.

“In the northwest of the country, some 4.4 million people, including more than 3.5 million women and children, are in need of humanitarian assistance.

“They depend on the cross-border access for their healthcare, their vaccines and medicines.

“We hope the Security Council will continue to find an agreement to preserve the health and welfare of this highly vulnerable population,’’ he said 

The Sales Process

0

 

Brian Tracy- endorsed speaker and training consultant
George O. Emetuche

“If you can’t describe what you are doing as a process, you don’t know what you are doing.” – W. Edwards Deming

Every endeavour follows a process. It takes process to achieve a goal. As we already know the importance of salesmanship and selling to business, it is vital that we discuss sales process as well.

Before we continue, it is imperative to note that there are inbound and outbound sales. At the most basic stage, the difference between the two sales is in who initiates the sales relationship. Inbound sales processes get started by the prospect, while outbound sales are started by the sales representative. It is important to note this distinction before we proceed in the discussion.

The focus of the sales process we will explore here is outbound sales which is a branch of business-to-business sales. It refers to the process of a seller, usually a sales rep of a company, initiating engagement with a prospect or prospective buyer through sales activities, such as cold calling, email prospecting, social selling and networking.

Understanding and applying sales process is what makes a sales professional. The teaching I will explore here is ideal for sales professionals, entrepreneurs, start-ups and professionals who want to create value with their products and services.

Components of the sales process

Reach out to the right market

This is the art of prospecting and the first stage in the sequence. You need to reach out for the sales. You need to make the sales to happen. Selling is about  being strategic. You need to prospect and identify where the buyers are. It is not every market that is made for your products or services. You must discover your own market. You must sell the right product; you must sell the right way; and you must sell in the right market. I believe that if you sell the right product in the wrong market, it will fail. If you sell the wrong product in the right product, it will fail.

As a businessperson, start-up or sales professional, you must identify the right market for your product. The right market means that you go to the market buyers and prospects that will need your products and services. You must take time to identify this market. You need to know who buys, what they buy, where they buy, when they buy, why they buy, and how they buy. I call these The Five Ws and One H of Selling. This is how to sell productively.

Selling is strategic and intentional. It is strategic because you must plan how to achieve your goals, and intentional because you must design and go out to achieve what you designed.

Qualify your prospects to ensure you are talking to the right people

Identifying the right market is the first task for the business. This task is done before coming out with the products because you need to know the market your product is meant for. You don’t just manufacture; you produce for a market. When you have done this, the next assignment is to ensure that the prospect you are selling to in the market is the right prospect. The right prospect is identified by deploying questioning and listening skills. The salesperson asks the prospects questions skilfully to know if he needs the products, and if he can pay for the products.

Sales conclude when payment is made. If payment for products bought is not made, then sales didn’t happen. What happened is dumping, and dumping isn’t selling! So, qualifying the prospect is necessary to ensure that the business is dealing with the right person or market.

Develop a cordial relationship with your target audience

In selling, relationship is everything. This is true for business as well. People ‘‘buy’’ people. People buy from people they like and trust. When people like you because of the way you treat them, they will buy from you. When people know that they can trust you and your product, they will buy from you.

The more you develop cordial relationships with your customers and prospects, the more you sell. I deployed relationship strategy when I was in the field as a salesman. I invested time in building viable business relationships. The quality relationships I developed in the right places helped me to succeed in my days as a field salesman.

I agree with Brian Tracy when he said, ‘‘21st century selling is relationship selling.’’ The healthy professional relationships you built as a salesperson help you at tough times. People may decide to buy from a salesperson because of the person selling the product and not necessarily because of any other reason. I have seen this happen on several occasions. It is ideal to build quality and cordial relationships; it is ideal to sell value all the time. This is the way to succeed in the field of sales.

 

 

How Nigerian Pharma Sector can Replicate Advances in US Health System – Bruno Nwankwo

0

 

How Nigerian pharma sector can replicate advances in US health system - Bruno Nwankwo
Pharm. Bruno Nwankwo

Pharm. Bruno Nwankwo is an octogenarian pharmacist, a Fellow of the Pharmaceutical Society of Nigeria (PSN) and former chairman of the Pharmacists Council of Nigeria (PCN). He is also a pharmaceutical industry guru, having spent over two decades of his career in industrial pharmacy practice, where he not only rose to top executive positions at CIBA GEIGY but also helped to birth the Nigerian affiliate of the company. He also helped to set up the company’s manufacturing facility in Ota, Ogun State, before his retirement in 1992.

 

In this special interview with MOSES DIKE, Nwankwo who is now partly resident in the Unites States of America, reveals how the Nigerian pharmaceutical industry can improve, borrowing from the US experience. He also reminisces about his childhood and other significant events in his earlier years, while offering valuable advice to younger pharmacists on to how maximize their training for the benefit of humanity. Excerpts:

Kindly tell us  some of your early childhood experiences and the events that have helped to shape your adult personality.

I was born in September 1939, in Umuahia (Abia State), and my early life was spent in Umudike, where my dad was a staff of the Rural Education Centre. Being a teacher’s son, I was privileged to start school at the recommended age of five at St. Anna’s School, Ahia Eke, Ibeku, also in Abia State. I was enrolled into Class 1B, which today is referred to as the kindergarten class.

When my family travelled home to Ajalli (now Anambra State), for my father’s annual leave in December 1948, my parents left me in the village to continue my education at Government School, Ajalli. This practice was fairly common in those days. Dad had arranged that I live with a teacher in the school, who was his friend.

Life in the village was exciting but quite different from what you may call “city life” in Umuahia. I stayed in Ajalli, until October 1952, when I left for my secondary school education at Government Secondary School (GSS), Owerri – the school that largely made me.

GSS Owerri was one of the three secondary schools for boys run by the Eastern Nigeria Government, which, due to its appropriate funding, offered many opportunities in sports and academics. I was not found wanting in either of these. As is often said, “I did not just go through OGSS; the school indeed also went through me”, and I owe so much to my alma mater for who and what I have achieved.

By 15 September this year, you will clock 83 years of age. What does this new age mean to you and how does being an octogenarian affect your perspective of life? Are there new feats you still hope to achieve?

I am in my 80s now and rightly among the elders of Pharmacy in Nigeria. I count this a privilege and remain grateful to God that I belong here. Since my days in the university, I have identified with efforts to make Pharmacy in Nigeria a better profession. I was active in PANS (Pharmaceutical Association of Nigeria Students) and served in its executive committee while at school.

And in my brief stint in hospital pharmacy, I was active in the Nigeria Union of Pharmacy – the pharmacists group within the labour movement – producing position papers and materials for numerous petitions that preceded the recognition of Pharmacy in the professional cadre of the Nigerian Civil Service.

By the way, it was not until the early 70s that pharmacists were appointed into the grade for professionals. Prior to that, pharmacists were in the technical cadre.

My generation rightly paid its dues and, today, in retirement, we can look back and proudly cherish our contributions to what is today Nigerian Pharmacy.

You were among the first set of pharmacy students to obtain B. Pharm degree from the University of Ife, now Obafemi Awolowo University (OAU), Ile-Ife. How did the choice of Pharmacy as course of study come to you and what was the experience like studying in a pioneer B. Pharm class?

Growing up, I wanted to care for the sick and belonged to the First Aid team at school. We associated caring for the sick in the hospital with doctors and nurses. There were no pharmacists in the hospital. Medicines were handed out by dispensers.

After my West African School Certificate, in December 1957, I applied to and was admitted to the Nigerian College of Arts, Science and Technology, Enugu Branch, as a Pre-Medicine student and I registered for Physics, Chemistry and Zoology. The Pre-Pharmacy students were admitted for Physics, Chemistry and Botany.

It was here that I learnt of Pharmacy and my interaction with these classmates opened my eyes to a possibility of such a career. But my flirtation with it only started when Government announced suspension of Federal Scholarships for Medicine but not so for Pharmacy.

Following weeks of hard thinking, I wrote to my father to suggest my desire to change my course to Pharmacy. To my relief, he had no objection and I followed up with a formal application to the College.

With success in the GCE A Level, we were admitted to the Department of Pharmacy in the Nigerian College, Ibadan Branch, to study for the Diploma in Pharmacy, which I obtained in 1963. However, in our Second Year, the College transformed to the nucleus of the new University of Ife and we were given the opportunity to return in the final year of the B. Pharm students to graduate with them in the 1965/66 session.

Tell us about your work experiences. Which of them did you find most exciting and why was it so?

Upon gaining the diploma, I got registered as a pharmacist and reported to the Federal Ministry of Health to serve as required by a condition of my scholarship. I was posted to the Lagos Island Maternity Hospital. I had no job satisfaction. I sought and resigned after a year to join NIGARCO – a pharmaceutical company – as a medical representative and worked there until September 1965, when I returned to the University of Ife for the B.Pharm.

I graduated in 1966 with the premier University of Ife class and was employed as a graduate assistant in the Virology Unit of the UCH Ibadan. Unfortunately, I served here for only three months before the Nigerian civil war forced me back to my region and I went back to hospital pharmacy at General Hospital, Enugu.

During the Biafran War, I served with the Red Cross, where I managed their medical stores. At the end of the hostilities in 1970, I returned to the civil service and was posted to General Hospital, Onitsha.

My passion was for a place in industry and my opportunity came in 1970. CIBA-GEIGY offered me a job as a medical representative in Lagos. This was the start of a 22-year career and I progressed through product management to become head of the Pharmaceuticals Division and subsequently executive director.

In this capacity, I was responsible for the company’s pharmaceutical business in Nigeria and the Anglophone West African region. I retired in 1992 to become the chairman of Swiss Nigerian Chemical Company Ltd – the Nigerian affiliate of CIBA-GEIGY. During this period, the company established a pharmaceutical manufacturing facility in Ota.

In order to jointly tackle the regulatory and various adverse issues that confronted our business, managers of pharmaceutical companies in Nigeria held regular lunch meetings and ultimately joined the Lagos Chamber of Commerce and Industry as its Pharmaceutical Group. I had the privilege to succeed Pharm. Anyafulu as chairman of this group in 1986 and remained so until my retirement in 1992.

As chairman, we encouraged the formation of the Industrial Group of the Pharmaceutical Society of Nigeria which has blossomed to the NAIP (Association of Industrial Pharmacists of Nigeria).

Having had a stint in the Nigerian pharmaceutical industry and now partly resident in the USA, what policies or practices in the US would you like replicated here in Nigeria?

For some years now, I have had extended stays in the US and observed the practice of Pharmacy in that country. From my observation, the healthcare professions and providers are more strictly regulated. All practitioners understand their roles and are supportive of one another.

The competition and encroachment prevalent in the practice in Nigeria does not exist. Infractions are promptly recognised and penalised. Consequently, all healthcare providers practise as expected, and get the expected outcomes, vis-a-vis rewards and job satisfaction.

We should, however, note some factors which militate against us in Nigeria as follows: poverty and low literacy rate; low health insurance coverage; low pharmacist-to-population ratio etc. These encourage impersonators and charlatans who unfairly compete with the professionals. Elimination of these persons from the healthcare space will make a remarkable difference.

Tell us also about the low moments. Are there incidents or events in your years of practice that you wish never happened or should have happened differently? If you have the opportunity, is there anything about your life and career you would like to change?

On 4 May, 1966, I lost my father. This was a very devastating event. It was less than three weeks to my B.Pharm exams and I was distraught. Conflicting thoughts took me over. I was the eldest child of my family, so it was a life-changing event.

I remain grateful to my friends in NIGERCOL (as we called the Nigerian College), and in the neighbouring University of Ibadan, whose support helped me to get over my initial grief and to strategize on necessary next moves.

Despite the imminent degree exams, I travelled to Lagos that day to initiate plans for the funeral in my village. This was, with the cooperation of all necessary parties, done within a week and I returned in time for my exams.

Graduating just before the civil war posed several challenges among which were living in uncertain times, when there was no room for long-term planning – life, place of residence etc. – and what you did from day to day were uncertain. However, despite the vicissitudes of Iife in those days, I would still count them as very productive because you lived every day and there was no room for procrastination.

Tell us a little about your family. Did any of your children take after you to study Pharmacy or other health-related professions?

I married my wife, Lois, in 1971 and we have five children, one of whom is a pharmacist, although she is not actively practising Pharmacy. She graduated in the United States and returned to Nigeria with her husband. After a brief time as a community pharmacist, she was frustrated, unable to be as adaptive as our colleagues there. She returned to school to obtain a Master’s in Public Health and now works with an NGO.

How do you relax? Tell us about some of the pastime activities and lifestyle modifications you have adopted to stay fit and active.

As a young man, I actively played cricket and lawn tennis but, with age, I relax by playing golf. Today, with body pains and other health issues, I now mostly walk or use the tread mill.

Finally, what advice would you give to the younger generation of pharmacists on how to make the best use of their calling as healthcare professionals to impact humanity positively?

Pharmacy has been good to me and I have served it in various capacities offered to me, including as an officer in the PSN executive, being chairman of a Conference Planning Committee or the Board of Fellows. More especially, I have enjoyed the opportunity to briefly serve as the chairman of the Pharmacists Council of Nigeria.

My advice to pharmacists, especially the young ones, is to deliberately choose the aspect of Pharmacy they are passionate about and locate themselves there.

Success may not come immediately or even soon; but you will, at the least, have job satisfaction and be fulfilled.

How Alemede is Expanding Oncology Access for Underserved Nigerians

0

 

 

How Alemede is Expanding Oncology Access for Underserved Nigerians
Victor Dare Alemede

In Nigeria, access to oncology medications is a pressing issue, as cancer patients across the country, particularly those in underserved regions, often face significant hurdles in obtaining life-saving treatments. Rising to this challenge is Victor Dare Alemede, a visionary in the pharmaceutical sector with over a decade of experience in oncology and specialty care. Through innovative strategies and patient-centred initiatives, Alemede is redefining how oncology products reach those who need them most, making a profound impact on the Nigerian healthcare landscape.

Understanding the oncology access gap in Nigeria

Nigeria’s healthcare system faces unique challenges when it comes to oncology care. The country has a high prevalence of cancer cases, yet access to advanced treatments remains limited. Many patients in remote and underserved areas struggle to find consistent access to oncology medications due to high costs, distribution inefficiencies, and the prevalence of counterfeit drugs. Alemede’s work is grounded in a deep understanding of these issues. With experience working in oncology roles at prominent companies such as AstraZeneca, PharmaSymbiosis, and Roche, he has seen firsthand the gaps that exist in accessing quality cancer care. His work across multiple organisations and therapeutic areas has armed him with the knowledge and expertise needed to tackle the access problem from several angles.

 

Transforming access through strategic partnerships and market expansion

Alemede’s approach to transforming access to oncology products centres on forging meaningful partnerships and expanding market reach. During his tenure as an Oncology Products Specialist at Roche Nigeria, he developed strategies that significantly increased patient access to life-saving biologic therapies. By partnering with key pharmacies and healthcare institutions, he ensured that patients in even the most underserved regions could obtain the critical medications they needed. His efforts led to an astronomic increase in patient access to anticancer biologics—an accomplishment that stands as a testament to the effectiveness of his strategies. At AstraZeneca, he spearheaded a five-year strategic plan to grow the company’s oncology portfolio into a $10 million business. His initiatives went beyond sales; they were deeply focused on patient outcomes. Through partnerships with cancer centres and a commitment to strengthening relationships with healthcare providers, Alemede achieved a remarkable growth in sales, reflecting the significant impact of his strategies on patient access.

 

Leveraging data and technology for improved oncology access

Alemede is also a strong advocate for using data and technology to overcome access barriers in Nigeria’s healthcare system. At Pharmasymbiosis Ltd,  where he led the Sanofi Vaccine and Pharma franchise, he utilised data-driven insights to segment markets and prioritise high-need areas. This approach ensured that oncology and vaccine products reached the right facilities, increasing efficiency and expanding access to patients in need. Data analytics, as Alemede has demonstrated, is a powerful tool for making informed decisions about resource allocation and distribution strategies. By analysing historical sales and customer engagement data, he has been able to pinpoint high-demand regions and implement targeted distribution plans, which in turn reduce stockouts and improve drug availability for oncology patients. In the future, Alemede envisions an even greater role for technology in addressing Nigeria’s oncology needs. He is a proponent of digital platforms that connect patients and healthcare providers, as well as blockchain solutions for tracking medication authenticity. These innovations not only improve transparency in the supply chain but also provide a secure way to ensure that patients receive genuine medications, a vital step in combating the country’s issue with counterfeit drugs.

Breaking down financial barriers to essential oncology medicines

One of the most significant challenges in oncology care is affordability. Cancer treatments, particularly biologic therapies, are often costly, and many patients cannot afford them. Alemede’s strategies have consistently aimed to alleviate this burden. During his time as a Key Account Manager for Novartis, he developed partnership strategies with strategic accounts that enabled price reductions and made oncology treatments more affordable for patients. He believes that affordability must be tackled through both government intervention and private sector collaboration. He advocates for public-private partnerships that allow pharmaceutical companies to work alongside government agencies to provide subsidies and patient assistance programmes. By working with stakeholders across the healthcare ecosystem, Alemede has succeeded in reducing costs for essential oncology medicines, giving underserved patients a better chance at accessing the treatments they need.

Championing education and awareness in oncology care

Alemede understands that improving access to oncology medications requires more than just product availability; it also demands education and awareness. Patients and healthcare providers alike must be informed about the latest treatment options, proper medication use, and the importance of early diagnosis and adherence to treatment protocols. Throughout his career, Alemede has championed educational initiatives that equip healthcare providers with the knowledge they need to offer better care. At Roche, for example, he was instrumental in the pre-launch activities for two major cancer therapies, leading stakeholder engagements that prepared providers to effectively administer these new treatments. His dedication to education has empowered countless healthcare professionals to provide better care, which in turn improves patient outcomes and supports long-term healthcare sustainability.

A visionary leader for the future of oncology care in Nigeria

Alemede’s work is reshaping the future of oncology care in Nigeria. His initiatives have proven that patient access to essential oncology medications can be transformed through strategic partnerships, data-driven insights, affordability measures, and education. But perhaps most importantly, his leadership demonstrates that compassion and dedication to patients are the cornerstones of true healthcare innovation. His story is not just one of professional success; it’s a beacon of hope for millions of Nigerians affected by cancer. As he continues to push for greater access to life-saving oncology products, his efforts serve as a reminder that, even in the face of immense challenges, progress is possible. His work offers a model for how the pharmaceutical industry can drive meaningful change, not just in Nigeria but across Africa.

For Nigeria’s healthcare system, which is still grappling with the complexities of providing comprehensive oncology care, Alemede’s contributions represent a bold and necessary step forward. His vision for a healthcare system where every patient, regardless of financial status or geographical location, has access to essential oncology medicines is a testament to his unwavering commitment to health equity. In a field where so much is at stake, Alemede’s work stands as an inspiring example of how dedication, innovation, and a patient-centred approach can create lasting impact. His journey is redefining what it means to access oncology products in Nigeria, and his legacy will undoubtedly pave the way for a future where every cancer patient receives the care they need and deserve.

Clina Lancet Wins 2022 Private Laboratory Service Provider of the Year Award

0

 

Clina Lancet Wins 2022 Private Laboratory Service Provider of the Year Award
L.R: Olatunji Fadeiyi, finance manager; Aliu Israel, national lab manager; Dr Olayemi Dawodu. MD/CEO, Clina-Lancet Laboratories Nigeria; Peace Emelike, human resource executive; Eluwa Izubundu, business development executive, in a group photograph at the Clina Lancet Laboratories headquarters, Victoria Island, Lagos.

Clina Lancet Laboratories, a leading ultramodern and independent pathology laboratory with branches across multiple states has won the 2022 Nigeria Healthcare Excellence Award for Private Laboratory Service Provider of the Year.

The 8th Edition of the award which took place on the 24th of June at the Eko Hotels and Suites, Victoria Island, Lagos, was organised by Global Health Project and Resources (GHPR) in collaboration with Anadach Group USA to recognise and honour individuals and organisations who have contributed remarkably to the country’s health sector.

 

L-R: Dr Olayemi Dawodu, MD/CEO, Clina-Lancet Laboratories Nigeria; Dr Olohirere Umelo, operations manager and Olatunji Fadeiyi, finance manager.

Clina Lancet Laboratories emerged the winner of the Private Laboratory Service Provider of the Year Award for its contribution towards providing Nigerians with accurate and advanced medical pathology services to stay healthy and promotion of improved outcomes for patients.

The laboratory won the highly coveted award category which seeks to recognise leading private laboratory service providers in Nigeria, who through innovation and undisputed quality services have remarkably contributed to the advancement of the healthcare sector.

The Managing Director/CEO of Clina Lancet Laboratories, Dr Olayemi Dawodu, in a statement acknowledged NHEA for their commitment to the advancement of the country’s healthcare sector by honouring professionals and organisations including private laboratory service providers, whose works she described as pathology being the umpire of medical profession.

She also expressed her gratitude to the indefatigable team at Clina Lancet, whose diligent work and contributions has helped to scale the laboratory to Nigeria’s fastest growing independent pathology laboratory. She further reiterated Clina Lancet’s commitment to providing optimal diagnostic services to patients using advanced technology across all laboratories in the country.

The Natural-Born Nurse Leader and Reformer

0
The natural-born nurse leader and reformer
Dr Gloria Olubosola Rowland

The narrative of Dr Gloria Olubusola Rowland’s emergence as one of the most illustrious nurse leaders in the United Kingdom is one that is both intriguing and inspiring. Despite her humble background and training in Saki, Oyo State, Nigeria, she has consistently distinguished herself as a transformational nurse leader and visionary.

She is presently the Chief Nursing Officer and Executive Director of quality for the entire North West London. Before then, she was the director of midwifery at Barts Health NHS Trust, which has the largest maternity services in the UK. That post was an iconic one for Rowland, as it established her as the first Black African director of midwifery in the history of maternity services in the UK.

The UK’s Nursing Times in describing her, says: “Dr Rowland has received national recognition for her work in transforming maternity care including chairing the trailblazer group that developed the new apprenticeship pathway into the midwifery profession.” The Nursing and Midwifery Council of UK concurs, saying: “She has a strong passion for change, innovation and transformation of health services.”

Significant beginnings

Growing up in her rural community in Oyo State, Rowland’s initial intention was to study Medicine. However, when she attempted the entrance examination (Unified Tertiary Matriculation Examination) the first time, she was offered Physiotherapy. She rejected the offer and decided to write the examination the following year.

Fortunately however, her mother, who was also a prominent health professional, encouraged her to enrol for the Nursing programme at the Baptist School of Nursing in Saki. The plan was for her to have some basic knowledge of key areas in the medical sciences, such as Anatomy and Physiology, while preparing to take another UTME. However, once she began her training, it dawned on her that Nursing was what she was born to do and she decided to complete the programme.

Signs that Rowland was going to be an exceptional nurse began to manifest, soon after she graduated from the nursing school. Having been trained to “nurse from the heart”, she approached her practice with unusual commitment and sense of duty. She found herself being drawn to patients that many other nurses would not be comfortable attending to. For example, there were nomadic herdsmen in the bushes and forests surrounding the village in which she practised, some of whom had very poor hygiene habits. When such visited the clinic, many nurses tried to avoid them but she always wanted them for herself.

Rowland however faced a major challenge that increasingly diminished her zest for the profession she had come to love. Nurses were often considered inferior and treated as servants by the physicians. According to her, “I enjoyed the training. But when I started working, the things I saw and how nurses were treated – you had to give water to the doctors, kneel for the doctors, and in the theatre, you had to wipe their faces while sweating – I didn’t like that. I knew that was not what I wanted to do.”

With her dissatisfaction mounting, Rowland began to seek a means of escape from what she had come to consider a stifling work environment. Moreover, having been given a horrible first impression about nursing practice, she decided that she would return to the medical field to do her further studies.

Greener pastures

Rowland’s much-awaited moment of “escape” came when she won a scholarship to study Medical Law in the UK. As Providence would have it however she spent her first few days with a family in the UK, in preparation for her resumption. The family convinced her that since she already had a background in Nursing, it was better for her to continue. The argument was that the prospect of getting immediate employment after graduation was very high and her student visa gave allowance for switching her intended course of study.

Rowland made the smart decision of personally researching how nursing practice was being done in the UK and much to her surprise and relief, the setting was totally different. She thereafter proceeded for her adaptation programme which qualified her to be a registered nurse. Soon after obtaining her B.Sc Nursing and Midwifery, she bagged a master’s degree in Public Health from Brunel University, London, and subsequently did her Doctorate in Clinical Practice at the University of Southampton. Essentially, within the space of a few years, she had qualified as a midwife, specialist community public health nurse, and doctor of clinical practice.

Impactful career

Given her solid background, robust professional training and natural passion for excellence, it is no surprise that Rowland’s years in service as a nurse leader have been garlanded with notable accomplishments.  Having demonstrated broad expertise and meritoriously risen through the ranks of the leadership of the UK’s health system, she was made director for Midwifery at Bart’s Health NHS Trust in 2018.

Despite the upsurge in her responsibilities as the head of the UK’s largest maternity service, Rowland wasted no time in bringing to bear the transformational approach to nursing leadership that had become her trademark over the years. Indeed, just two years into her appointment, Bart’s Health NHS Trust reported that she had “made considerable improvements to our maternity services and was recognised by CQC Chief Inspector Ted Baker for ‘outstanding practice in the leadership and drive shown.’”

As is common with exceptionally productive people, the turbulence that characterised year 2000 proved to be a catalyst for even greater accomplishments for Rowland. Naturally, with the outbreak of COVID-19, the celebrated nurse leader had more challenges to contend with, with higher numbers of women and expectant mothers falling ill. Even more, she observed that the pandemic was affecting a disproportionate number of people from Black and minority ethnic communities, including her nursing colleagues.

However, rather being daunted by these unforeseen challenges, she rose to the occasion and confronted them headlong with unprecedented initiatives, some of which have continued to yield results even after the pandemic. One of such lasting initiatives is the Turning The Tide Project.

The project had emerged from her discussions with several of the heads of maternity in the UK, who she ultimately led to compile a report highlighting the historic and endemic inequalities faced by Black and Asian healthcare professionals in the NHS, and those of mixed ethnicity. Findings of the report were shared with the concerned regulatory authorities. In response to the findings and recommendations, the Royal College of Nursing recently launched a new mentoring scheme to support Black, Asian, and minority ethnic midwives and maternity support workers (MSWs) in their career development.

Recognitions and awards

In celebration of her immense contributions to the advancement of nursing practice and healthcare delivery, Dr Rowland has won several honours and recognitions. In 2021, Her Majesty, Queen Elizabeth II, awarded her an MBE, one of UK’s most prestigious awards. Earlier in 2020, she was appointed to the National Advisor Group of the UK’s Chief Nursing Officer, so she could use her wealth of experience in helping to provide an effective response to the COVID-19 outbreak. Additionally, she was made a Florence Nightingale Research Scholar in 2011 and a Mary Seacole Scholar, two years earlier (2009).

Katsina Records First Monkeypox Case, Awaiting 15 results, Says Commissioner

0

 

Katsina Records First Monkeypox Case, Awaiting 15 results, Says Commissioner
monkeypox virus image

Katsina State says it has recommended the first case of Monkeypox disease, treated and discharged the patient.

The state’s Commissioner for Health, Mr. Yakubu Danja, confirmed this at the distribution of medicare and free medicines to the 34 Local Government Areas of the state in Katsina.

Danja also disclosed that the medicare and free medicine would be distributed to call centres across the state.

He said the government had proactively activated all emergency response teams to curtail the further spread of the disease in the state.

According to him, the state has about 15 suspected cases, whose samples have been taken to Abuja, and are awaiting the results.

He added that the distribution of the medicines was to proactively deal with the disease, as well as cholera and other rainy season-related diseases.

The Commissioner also inspected the fully equipped Emergency Operations Centre, called the ‘Call Centre’, and the 140 Solar Direct Drive Vaccine Refrigerators.

He said that the facility was donated by the National Primary Health Care Development Agency, to ensure vaccine potency, and to reduce the cost of distribution.

The Executive Secretary of the Agency, Dr. Shamsudeen Yahaya, said all the interventions, especially the distribution of medicare in the state, are to be readily proactive against any unforeseen circumstances, especially with the setting in of the rainy season.

According to him, the Call Centre will serve as a mechanism to log field or community reports on suspected diseases or deaths.

He added that it would also enhance the ability for the early detection, prevention, and response to disease outbreaks, or other events of public health importance. 

WAPCP Partners DELSUTH to Launch First Pharmacy Residency in West Africa

0

 

WAPCP Partners DELSUTH to Launch First Pharmacy Residency in West Africa
L-R: Pharm (Dr) Francis Odigie, head of service, Orhiowan Local Government Area, Edo State; Pharm. (Dr) Ukamaka Okafor, secretary, WAPCP Nigerian Chapter; Pharm(Dr) Margaret Obono, chairman, WAPCP, Nigerian Chapter; Prof. Azuka Opara, chief examiner, chairman, Joint Faculty Board, WAPCP; Dr Teresa Pounds, member, International Accreditation Commission, of the American Society of Health System pharmacists (ASHP); Prof. Onome Ogueh, chief medical director, DELSUTH; Rev. (Dr) Lucky Otegheri, chairman of the occasion; Dr (Mrs) Magdalene Oke, H.O.D of Pharmacy, DELSUTH; Professor Ibrahim Oreagba, secretary general, WAPCP; Prof. Noel Wannang, immediate past secretary general WAPCP and Dr David U. Adje, representative of President PSN, in a group photograph at the inauguration of the International Pharmacy Practice Residency in DELSUTH, Oghara, Delta State, recently.

 

To further enhance pharmacists’ capacity in clinical practice, the West African Postgraduate College of Pharmacists (WAPCP), in collaboration with the management of Delta State University Teaching Hospital (DELSUTH), Oghara, has established the International Pharmacy Practice Residency (IPPR) programme.

The IPPR, being the first of its kind in the West African sub-region, and the second in Africa, after Egypt, will be accredited by the American Society of Health System Pharmacists (ASHP), which will also award certificates to Fellows of the WAPCP at the conclusion of the training.

The ASHP has, since 1963, served as the sole accreditation organisation for pharmacy residencies and pharmacy technician training programme in the United States of America.

During an exclusive interview with Dr Teresa Pounds, who was the brain behind the new initiative, she said her experience and role at the ASHP made her realise that WAPCP can derive huge benefit from embracing the idea of international residency for students of the institution.

She added that, fortunately, the leadership of the college bought into the idea, following which discussions ensued for about a year and half, culminating in the recent inauguration.

Pounds, who is the current president of the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA), said: “I was appointed to the ASHP International Accreditation Commission (IAC) in August 2020 for three years. Due to my role in the position, I was able to note that WAPCP would benefit with the information I had to share with them to see how they could restructure the current residency programme that they have, and the leadership team of WAPCP was very receptive to my recommendation and thought because I had pretty much told them what they needed to restructure their programme and focus it more on practice.

“Although the WAPCP programme was great, it needed a little more of exposure to the practice aspect. That was where the discussion started from about a year and half ago, when I started working with Prof. Ibrahim Oreagba, secretary general, WAPCP; and President Prof. Cecilia Igwilo, on the idea, before it eventually materialised this year.”

She continued: “The reason why the new residency programme is so important is that patients are the ones to benefit more. This residency programme is focused on what is called the patient-centred care; meaning, the patient is the centre of everything, not the physician, the pharmacist, or any other person.

“The residents will be trained to be able to work averagely with doctors and nurses and other healthcare personnel. The doctors will still be in charge of patients but the residents will do better in supporting doctors and nurses, when it comes to medications therapy management.”

On the choice of DELSUTH for the maiden edition of the residency training, Pounds noted that the management cordially keyed into the idea, and thus positioning the institution to be the first in West Africa to run residency for pharmacists.

She added: “I have received lots of calls from different teaching hospitals, saying they are interested. The plan that WAPCP has is that any institution that has the interest in doing it will be added later.”

Also speaking on the inauguration of the residency programme, the Nigerian Chapter Chairperson of WAPCP, Pharm. (Dr) Margaret Obono, acknowledged Pounds as the initiator of the initiative in Nigeria, by facilitating the alliance between WAPCP and ASHP, which, she said, will enable pharmacists to work with other healthcare professionals for the maximum benefits of patients.

“With this collaboration, pharmacists optimise medication therapy, reduce medication errors drastically; unnecessary expenditure on drugs is prevented, prolonged hospital stay is prevented and even morbidity is drastically reduced. Most of these challenges arise due to irrational drug use and so require the intervention of pharmacists to help patients get maximum benefits from their drugs,” she said.

Expressing her delight in the commencement of the two-year programme at DELSUTH, Obono remarked that if it is replicated in other health institutions in Nigeria, patients will testify to its benefits and the country’s health indices will improve.

In her contribution, Pharm.(Dr) Amaka Okafor, secretary of the Nigerian Chapter of WAPCP, revealed that the programme is based on the mentorship and coaching model that allows pharmacists to apply the knowledge and skills learnt in school to real patients, situations and settings, in specialised conditions.

She noted that, after the programme, pharmacists will become clinician pharmacists with expertise in special practice areas, such as oncology, intensive care, and so on.

According to her, “It is what the person learns during the residency that he or she will apply. The more specialised care we have, the better for our healthcare service delivery.”

PWDs: NAWOJ, Albino Foundation Sign MoU to Promote Inclusion

0
PWDs: NAWOJ, Albino Foundation Sign MoU to Promote Inclusion
NAWOJ Img

Nigeria Association of Women Journalists (NAWOJ) and The Albino Foundation (TAF)
signed a Memorandum of Understanding (MoU) to promote inclusion of Persons with Disabilities (PWDs) and other marginalised groups in the society.

The National President of NAWOJ, Mrs Ladi Bala, said during the signing of the legal documents on Tuesday in Abuja,that the MoU would give more visibility to issues affecting PWDs and other vulnerable groups in the country.

Bala says journalists are critical stakeholders in advancing the cause of governance, hence will use their platforms to create space that will highlight and bring necessary changes on issues affecting PWDs.

He added that “our role is to create visibility on their issues and we also need to galvanise the society to see them as normal human beings with equal rights.

“They should not be looked down on, their rights should not be trampled upon and their dignity should be upheld.

“We are concerned about that and because we have the platform and as part of our constitutional responsilities as watchdog of the society, we decided to build the capacity of journalists nationwide to understand issues on PWDs.

“This is because when they understand it better, they will be able to craft their messages in such a manner that it will elicit the kind of response from the members of the society.

“We should conscientise the society and mobilise them to give the necessary support to these people, give them their space and their rights must be respected and their dignity upheld,” she said.

According to her, the association has over 15,000 members nationwide; hence it will highlight issues of PWDs on their media spaces.

She, however, explained that inadequate funding had been a bane in achieving some of its goals, and urged development partners and other stakeholders to support the organisation.

Mr Jake Epelle, the Founder of TAF, said the MoU was apt, as it would further highlight issues affecting PWDs and ensure full implementation of the Disability Act.

Epelle added that the newly inaugurated members of the Journalists for Disability Inclusion would ensure increased visibility on inclusion for marginalised members of the society.

Esme Stuart, Programme Manager on Gender and Human Rights, European Union (EU), reiterated the commitment of the commission to ensure the rights of PWDs were respected.

She said “disability rights are key priority and the EU has a disability rights inclusion strategy that focuses not only on our programme but ensures disability inclusion in our organisation.

“Today’s signing of MoU brings in two key priorities for the EU, including women’s rights, gender equality and the rights of PWDs.

“We are working to make it more inclusive, not only because it is a human rights but we believe it makes the society better and more inclusive.”

Mr Chris Isiguzo, the National President of the Nigeria Union of Journalists (NUJ), said the MoU would enable the media to prioritise issues affecting PWDs like the disability act and its level of implementation.

He said “now the media will begin to talk about PWDs because we are talking about a group of persons that cannot talk for themselves.

“Now the media will become their voice and begin to talk about issues that concern them and these are the primary essence of the partnership between NAWOJ and The Albino Foundation.

“NAWOJ will begin to galvanise support from the media community, affiliate organisations so that the essence of this partnership will not be lost.”

NSSF Proffers Solutions to Brain Drain in Health Sector

0
NSSF proffers solutions to brain drain in health sector
NSSF Img

The Nigeria Solidarity Fund (NSSF) has proffered solutions and recommendations to stem the rising brain drain in the nation’s healthcare system.

This is contained in a communique issued by Dr Fejiro Chinye-Nwoko, the General Manager/ Chief Executive Officer, NSSF, on Saturday in Lagos at the end of its talk shop on brain drain in the health sector.

The discussion was entitled: “Nigerian Healthcare System and Brain Drain — Step up or Sink”.

NSSF said that the discussion was organised as an advocacy strategy with the aim of highlighting current challenges in human capital flight in the Nigerian health sector, and proffering solutions to same.

The discussion was also a rallying call for individuals and organisations to partner with the NSSF on strengthening the healthcare system in Nigeria.

The communique highlighted the following challenge’s in Nigeria’s healthcare system; poor working conditions stemming from epileptic power supply, dilapidated hospitals, inter-professional rivalry, security challenges exposing doctors to kidnapping and harassment from patients’ relatives.

Others included non-existent training opportunities, delays in payments of salaries lasting as long as 23 months in states such as Abia and Imo; and poor follow through of government policies.

The communique argued that it was difficult to train a doctor today to replace the experience and knowledge of consultants who were leaving the country.

According to the communique, the enumerated factors above are in stack contrast to conditions in the West, where salaries and emoluments are paid in a timely fashion; equipment are available and modern; and general conditions are conducive.

The communique noted that NSSF seeks to address this by identifying and funding high impact solutions in line with government strategies.

“Support for human resources for health is in line with the NSSF’s priority of strengthening the healthcare system which is a complex system that is incomplete without available healthcare workers.

“NSSF pools resources from individuals and corporate organisations to support national response to the COVID-19 pandemic which has impacted various sectors and worsened migration of healthcare workers,” the communique said.

The communique, however, acknowledged the efforts made by government in solving the problem of brain drain.

“This included: examining the statistics and the push factors, embarking on a reform programme chaired by Vice president, Professor Yemi Osinbajo.

“Negotiating for better pay and infrastructure, establishing the National Health Act to empower workers.

“Establishing the basic health care provision fund, which was created as a source of sustainable and predictable financing for health.

“Exploring mutually beneficial partnerships with countries that have high numbers of Nigerian healthcare workers in a bid to strengthen the healthcare sector in Nigeria

The communique said that if the recommendations were implemented, brain drain in the nation’s healthcare sector would be a thing of the past.

It said that government should commit to implementing agreed policies such as hazard allowance which took eight months to negotiate and is yet to be implemented.

According to the communique, government should convene roundtable discussions with relevant stakeholders to discuss workable solutions.

“Government should identify data gaps and research agenda and use the information gathered to understand and address brain drain as well as the risks of the health care system completely breaking down.

‘Government should work toward increasing patriotism by meeting the basic needs of the average citizen and creating an enabling environment,” it added.

Improving Blood Donation System In Nigeria

0
Improving Blood Donation System in Nigeria.
Blood Donation

On 14 June, 2022, Nigeria joined the rest of the global community to mark the World Blood Donor Day. The annual commemoration was created to raise awareness of the need for safe blood and blood products, as well as to urge governments and national health authorities to provide adequate resources, systems and infrastructures to increase the collection of blood from voluntary, non-remunerated blood donors.

The theme of this year’s event, “Donating Blood is an Act of Solidarity. Join the Effort and Save Lives,” is a vital one that must be amplified across Nigeria and taken seriously by both government and the citizens alike. The focus, as the World Health Organisation (WHO) has noted, is to emphasise the need for committed and consistent blood donation, as well as to ensure timely access to safe blood transfusion. This is imperative as safe blood and blood products are becoming increasingly essential and critical to medical care and public health.

This message is of particular importance to Nigeria, as figures have consistently shown that the rate of voluntary blood donation across the country is currently at an abysmal level. With its over 200 million population, Nigeria is estimated to require an average of 1.8 million pints of blood annually to maintain the health of its people. However, reports from the country’s agency in charge of blood donation – the National Blood Service Commission (NBSC) – show that the agency is only able to collect about 600,000 pints of blood every year, leaving a shortfall of about 70 per cent. This poor culture of blood donation calls for the attention and action of all stakeholders in the health sector.

It was perhaps in view of this that the Minister of State for Health, Dr Olorunnimbe Mamora, while briefing newsmen on this year’s celebration, highlighted the significance of blood donation as an act of kindness, unity and harmony which every citizen of the country owes their various communities. He added that blood donation plays crucial roles in the reduction of infant and maternal mortality, deaths from traffic injuries, surgeries and other conditions, while ensuring the safety of blood units in hospitals. “It is an indispensable aspect of healthcare that contributes to saving lives in Nigeria”, he said.

Indeed, beyond the routine commemorative activities, there is need for more concerted efforts towards the actualisation of the objectives of the World Blood Donor Day in the country. The 17 blood donation centres currently operated by the NBSC across the six geo-political zones are apparently inadequate to cater for the country’s blood needs. Moreover, with increase in the activities of insurgents and other deadly armed groups, the need for more blood banks and donation centres cannot be overemphasised as many victims of these armed groups often die of blood loss and lack of emergency medical care.

In the aftermath of the recent terror attacks on a church in Owo, Ondo State, the Nigerian Medical Association (NMA) and other groups raised the alarm that there was shortage of blood to treat some of the victims and therefore pleaded for blood donations. While such calls might sometimes be expedient, we wish to state that times of emergencies are not the best to mobilise citizens for blood donation. As the WHO has noted, blood donation must be a year-long event and citizens must be mobilised and encouraged to voluntarily contribute to blood banks.

It is also concerning that reports from blood donation centres have shown that Nigerians are more disposed to paid blood donation than voluntary blood donation. Haematologists have decried this practice, noting that voluntary blood donation is the safest source of blood and blood products for patients. The NBSC has also pointed out that commercial donors are more likely to live high risk lifestyles and have a higher burden of transfusion-transmissible infections. Moreover such paid donors are also often unwilling to disclose their true health status, since their motivation for donation is monetary and not altruistic.   This also underscores the need to constantly enlighten the public on the benefits of voluntary blood donation.

There is also the crucial need to effectively manage donated blood to ensure that more patients are able to benefit from the available supply. Recent medical studies have revealed that patients’ blood needs differ, as the various components of a pint of blood can save up three to three lives. This is a departure from the old procedure in which a whole pint is administered on a patient, regardless of their specific need. In view of this, we agree with the recent call by Prof. Vincent Osunkalu, a consultant haematologist at the Lagos University Teaching Hospital (LUTH) that physicians must begin to embrace the practice of blood fractionation. We believe that this will tremendously optimise availability of blood to more patients who need it.

We also urge hospital managements to promptly attend to road accidents victims and others in emergency need of blood, rather than first demanding payment. It is imperative to seek to save lives first before any other consideration, as a life lost can never be regained.

Harvest of Awards, as Sanwo-Olu, Alpha, Emzor, Others Shine at NHEA 2022

0

 

A cross-section of the entourage of Prof Akin Abayomi, commissioner for health, Lagos State, receiving the award plaque on behalf of Gov Babajide Sanwoolu at the event.

 

It was a harvest of awards with glitz and glamour at the 8th Annual Nigerian Healthcare Excellence Award (NHEA) ceremony held at the Eko Hotel and Suites, Victoria Island, Lagos recently as well-deserving organisations, healthcare professionals and eminent personalities from both pharmaceutical and medical sub-sectors were honoured with different categories of awards.

Speaking during the award presentation ceremony, Prof. Osagie Ehanire, minister of health, and his counterpart, Dr Olorunnimbe Mamora, minister of state,  who were both represented by Dr Adedamola Dada, chief medical director, Federal Medical Centre, Ebute Metta, explained that the award ceremony was timely as it came at a time the country had successfully contained the COVID-19 pandemic and its variants which according to him had threatened the economy of the country and the delivery of healthcare services to Nigerians.

“The primary purpose of recognising and rewarding healthcare professionals that have contributed to the efficient and quality healthcare delivery is to foster excellence and sustain quality healthcare to those that need medical care. Good healthcare is the prerogative of this government to Nigerians, so rewarding excellence plays a pivotal role in providing and sustaining a means by which good healthcare delivery is achieved”, he said

Also speaking after receiving his Special Recognition Award as Health Tech Governor of the Year, Governor Babajide Sanwo-Olu, who was represented by the Commissioner for Health, Prof. Akin Abayomi, noted that healthcare in the country is faced with a plethora of challenges, adding that public and private sector providers, as well as industry players, find  innovative way to thrive in their quests to care for the patients, adding that they keep striving to improve their capacity.

In other categories of the award for 2022, Chief Adebowale Omotosho, chairman, Bond Group, an industrialist, philanthropist, and renowned pharmacist cum elder statesman; Prof Ekanem Ikpi Braide, a renowned educationist, former vice-chancellor, Cross River University of Technology (CRUTECH), and pioneer vice-chancellor, Federal University, Lafia, Nasarawa State, and Prof. Joseph Oyeniyi Aina, an Emeritus Professor of Nursing, were presented with Lifetime Achievement Awards to rousing applause from the audience.

Also, Special Diaspora Healthcare Excellence Award was given to Prof.  Ohwofiemu E. Nwariaku, while the TB Special Recognition Award for the Most Outstanding Private Sector Advocacy Support for TB of the Year was given to Leadway Assurance, and TB Advocacy and Impact Organisation of the Year were given to Wellness HMO and Verod Capital.

 

Harvest of Awards, as Sanwo-Olu, Alpha, Emzor, Others Shine at NHEA 2022
Chief Adebowale Omotosho, chairman, Bond Group, a Recipient of the Lifetime Achievement Awards receiving his plaque from the representative of the Health Minister, Dr Adedamola Dada, chief medical director, Ebute Metta Federal Medical Centre.

The award in recognition of outstanding contributions to critical interventions for advanced cleft and surgery training simulation as well as the creation of the first cleft e-registry in Nigeria was given to Smile Train Incorporated, while Sterling Bank Most Responsive COVID – 19 Testing Company of the Year was won by Medbury Medical Service.

In the same vein, Sterling Bank Most Outstanding Genomics Laboratory of the Year Award was won by African Centre of Excellence for Genomics of Infectious Diseases (ACEGID) Redeemers University, Ede; Sterling Bank Most Outstanding COVID -19 Consumables Manufacturer of the Year (Indigenous) was won by Seven-Up Bottling Company Limited, while Sterling Bank Most Outstanding State for COVID – 19 Vaccination Award was won by Nassarawa State.

This year Outstanding Healthcare Financial Institution of the Year Award was won by Polaris Bank, while the Healthcare Media Excellence Award (Print), as well as Online, were won by Pharmanews and Nigeria Health Watch respectively.

State Government Health Insurance Scheme of the Year went to Katsina State, Private Healthcare Provider of the Year went to Evercare Hospital, while the Private Laboratory Service Provider of the Year, went to Clina-Lancet Laboratories, and Radiology Service Provider of the Year was given to Clinix Healthcare.

The award for Pharmaceutical Manufacturing Company of the year went to Emzor Pharmaceuticals Limited, while Alpha Pharmacy and Stores Limited, was honoured as the Pharmaceutical Retail Outlet of the year, and DrugstocEhub Limited went home with Technology-Driven Distributor Company of the Year.

Also, GE Healthcare won Hospital Equipment Marketing Company of the Year, Biomedical Engineering Service Company of the Year went to JNC International, and Laboratory Equipment Marketing Company of the Year was won by DCL Laboratory Products Limited, Abuja

In other categories, Physiotherapy Service Provider of the Year went to PhysioCraft; Most Outstanding Oncology Centre of the Year, won by Marcelle Ruth Cancer Centre and Specialist Hospital; Dental Service Provider of the Year, won by Beaconhill Smile Clinic; Eye Care Service Provider of the Year, won by Eye Foundation Hospital; Dialysis Service Provider of the Year, won by Zenith Medical & Kidney Centre, Abuja; IVF Service Provider of the Year, won by Nisa Premier Hospital, Abuja.

Others were, Most Active Facility on the SafeCare Quality Platform, won by General Hospital, Agbowa; SafeCare Facility of the Year, won by Evercare Hospital; Innovative Healthcare Service Provider of the Year, won by 54 Gene; Health Maintenance Organisation of the Year, won by AXA Mansard Health.

Speaking at the award ceremony, Sir Ifeanyi Atueyi, publisher, of Pharmanews, expressed his delight with the NHEA, which he said has carved a niche for itself in the healthcare sector, adding that its performance had continued to improve every year.

According to the octogenarian pharmacist, he was selected in 2015 as the first pharmacist in the country to receive the most prestigious Lifetime Achievement Award, saying despite the fact that he has numerous awards to his credit, the NHEA Award gave him the greatest joy because it embraces the entire healthcare sector.

Also speaking, the Chairman Advisory Board of NHEA Dr Anthony Omolola, applauded the contributions of all the nominees and winners to the development of the healthcare sector in the country, adding that the NHEA Award is an annual event that celebrates distinguished personalities and organisations who have contributed immensely to the growth of the Nigerian health sector.

He stated that NHEA which started in 2014 has become a high-profile event in the healthcare industry, gaining wide acceptance from stakeholders in the healthcare community, and public and private sectors. He added that the award is an initiative of the Global Health Project and Resources in Partnership with the Anadach group.

“Over the years, the NHEA has endeared more awareness on the quality and standards of services provided by various stakeholders in the industry, by inspiring them to adopt International best practices and aspire to be the benchmark for excellent healthcare service delivery in Nigeria and Africa in general.

“NHEA’s recognition aims to stimulate quality improvement and innovation in the Nigerian health sector leading to improved service delivery & management of key health issues and the capacity of individuals to influence and set new performance standards in Nigeria and beyond”, Omolola said.

Described as the Oscar of the health sector, the NHEA is jointly supported by Global Health Project & Resources (GHPR) in collaboration with the Anadach Group in the United States.

Dignitaries at the event include the Minister of Health, Dr Osagie Ehanire and Minister of State for Health, Dr Olorunnimbe Mamora, who were both represented by Dr Adedamola Dada, chief medical director, Ebute Metta Federal Medical Centre; Governor Babajide Sanwo-Olu, represented by Prof. Akin Abayomi, commissioner for health, Lagos State; Dr Ifedayo Adetifa, director-general, NCDC; Engr Yakubu Nuhu Danja, commissioner for health, Katsina State; Dr Olaokun Soyinka, former commissioner for health, Ogun State, and Pharm. (Sir) Ifeanyi Atueyi, publisher, Pharmanews, among many others.

 

 

WHO Concerned of Monkeypox Spreading to Children, Pregnant Women

0
WHO to Rename Monkeypox, Publishes Guideline on Vaccination
New Monkeypox Logo as uploaded by WHO

The World Health Organization expressed concerns about monkeypox spreading to vulnerable populations, as more cases continue to be reported in multiple countries.

On Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus said in a press briefing that the virus has now been identified in more than 50 new countries and that trend is likely to continue.

“I’m concerned about sustained transmission because it would suggest that the virus is establishing itself, and it could move into high-risk groups, including children, the immunocompromised, and pregnant women,” Tedros said. “We’re starting to see this with several children already infected.”

WHO is aware of two cases of monkeypox in children in the United Kingdom, and is following up on reports of cases in children in Spain and France.

Meanwhile, according to WHO Chief Scientist Dr. Soumya Swaminathan, immunocompromised individuals are at the highest risk of death from monkeypox.

Tedros said countries should increase their surveillance by increasing testing as quickly as possible, take a best practice approach to manage their response, engage communities actively, and ensure equitable access to medical countermeasures such as vaccines and antiviral medicines.

Vaccines offering protection for smallpox and monkeypox are currently limited in supplies, with stocks available in a few countries such as the United States.

Dr. Michael Ryan, executive director of WHO’s health emergencies program, said countries with stockpiles of these vaccines, including the U.S., have expressed willingness to share their supplies, and WHO is exploring the possibility of distributing them. But regulatory and ethics authorities in countries would have to look into the use of the vaccines and weigh their risks and benefits, particularly when considering their use among vulnerable populations such as pregnant people.

WHO is currently not recommending mass vaccination for monkeypox, but to targeted high-risk groups: preexposure prophylaxis for health workers and laboratory personnel at risk of exposure, and post-exposure prophylaxis for close contacts of cases.

“We can provide the data, we can provide the science, but national regulatory authorities must be able to look at the risks versus the benefits,” Ryan said, reiterating the need for researchers and regulators to come up with common standard protocols for the use of antivirals and for the use of vaccines.

This will enable their use “in the safest possible way — should it be needed — and that we can collect the data needed to ensure that we advance our scientific knowledge on efficacy and on safety,” he added.

COVID Vaccines Averted 19.8M Deaths, But Fewer Than 1% in LICs: Study

0
COVID vaccines averted 19.8M deaths, but fewer than 1% in LICs: Study
COVID-19 Injection

COVID-19 vaccines prevented 19.8 million deaths during the first year of rollout, and more could have been averted if additional people were inoculated, especially in low-income countries, according to a new study on the impact of immunization.

The modeling study, published Thursday in The Lancet, was carried out by researchers at the Medical Research Council Centre for Global Infectious Disease Analysis at Imperial College London in the U.K. According to a press release, it’s the first study to “estimate the impact of COVID-19 vaccinations on a global scale and the first to assess the number of deaths averted both directly and indirectly.”

The research covered 185 countries and territories whose populations were greater than 90,000 in 2019 and that had reported at least one death due to COVID-19 or one week when deaths were unexpectedly high compared with previous years. China was excluded “because of its unique position as the origin of the detected epidemic and its large influence on estimates of deaths averted stemming from its population size,” the study said.

Low-income countries accounted for fewer than 1% of all averted deaths, whereas high-income and upper-middle-income countries accounted for 62%. Lower-middle-income countries accounted for the remaining 37%. Almost 7.5 million of the prevented deaths were in countries covered by the advance market commitment of the international cooperative program COVAX.

India was the country with the highest number of averted deaths at 4.2 million, followed by the United States at 1.9 million and Brazil at slightly over 1 million. This is based on the study’s estimates of 31.4 million potential deaths if no vaccinations were carried out.

Oliver Watson, the study’s lead author, told Devex via email that the large number of averted deaths in India is due to its large population size.

“When you look at deaths averted per 10,000 people, they have 30.51 deaths averted per 10,000 people, which is comparable to many other lower middle income countries and more than the median estimate across all lower-middle income countries (22.23 deaths averted per 10,000 people),” he said.

About 15.5 million of the 19.8 million averted deaths were due to direct protection from vaccination, while the remaining 4.3 million were due to the reduced transmission of the coronavirus and improved access to medical care in countries seeing reduced pressure on the health care system.

Meanwhile, a further 599,300 deaths could have been averted if 40% of each country’s population was vaccinated by the end of 2021 — a goal that was set by the World Health Organization but not met. That includes 347,500 deaths in lower-middle-income countries and 200,000 deaths in low-income countries. A large proportion of those deaths occurred in WHO’s Africa and Eastern Mediterranean regions.

The researchers also modeled the number of prevented deaths according to officially reported figures. So if a country, such as India, sticks to its officially reported COVID-19 deaths, the number of prevented deaths changes. In the case of India, which has questioned the excess deaths estimate released by WHO, it would mean 3.4 million lives were saved instead of 4.2 million.

“[E]stimates of deaths averted are directly related to the source of deaths used and I think it would be fair to conclude that if country partners choose to report on the number of deaths prevented based on excess mortality, they are also choosing to report that excess mortality is more indicative of the true toll of the pandemic,” Watson said.

The study shows the benefits of vaccination but also highlights the fatal consequences of a lack of access. While experts say the supply of doses is now adequate to help nations vaccinate their populations, this was not the case in 2021, which was characterized by inequitable distribution and limited access for lower-income countries.

While “the intense focus on the pandemic has now shifted, it is important that we ensure the most vulnerable people in all parts of the world are protected from ongoing circulation of COVID-19 and from the other major diseases that continue to disproportionately affect the poorest,” said Azra Ghani, a professor and the chair in infectious disease epidemiology at Imperial College London, in the press release.

“Fair access” to vaccines means more than just donations, she said; it requires improvements in vaccine distribution and infrastructure, as well as in combating misinformation and improving vaccine demand.

To date, COVID-19 vaccinations continue to lag in many low-income countries. According to Our World in Data, only 17.8% of people in low-income countries have received at least one dose of a COVID-19 vaccine, with many nations yet to cover even 10% of their populations and thus expected to miss WHO’s 70% vaccination target set for the end of June.

But the focus has now shifted to getting these countries to reach their own targets and ensuring coverage for high-risk groups such as health workers, older people, and those with underlying medical conditions. COVID-19 vaccination efforts, however, face several challenges. The omicron variant has changed people’s risk perception of the threat of COVID-19, which likely needs to be addressed to increase demand for vaccinations.

Ted Chaiban, the global lead coordinator for the COVID-19 Vaccine Delivery Partnership, told Devex in early June about the importance of working with trusted community leaders to address the issue.

“We need to remind [people] that there’s still a risk of serious illness, there’s still a risk of death, especially among high priority groups,” he said.

 

Pharm. (Mrs) Folasade Lawal Is Our Personality For July

0

 

Pharm. (Mrs) Folasade Olufunke Lawal is the MD and CEO of Victory Drugs, a community pharmacy, based in Lagos, Nigeria. She is also a consultant at the Drug Information Centre, Association of Community Pharmacists of Nigeria (ACPN).

Lawal graduated from the University of Ife (now Obafemi Awolowo University) in 1985 with a Bachelor of Pharmacy degree. She further obtained a master’s degree in Clinical Pharmacy in 2006 from the University of Lagos.

She cut her teeth in the profession as a hospital pharmacist at Adebowale Hospital, Lagos, where she was in charge of services such as drug purchases and storage, drug dispensing, patient counselling and liaising with other healthcare professionals in the hospital. After working for a year in the hospital, she established her own company, Victory Drugs in May, 1989.

With 33 years of professional experience, the pharmacist has categorically carved a niche for herself in excellence. Aside from having a number of research publications to her credit, she is reputed to have developed several laudable innovations, among which is the popular “Your Pharmacist & You” programme, aimed at ensuring that patients keep track of their medical record.

An ardent community pharmacist, Lawal has been involved in numerous community programmes aimed at positive behavioural changes. These have been especially targeted towards curbing the spread of communicable diseases like HIV/AIDS and malaria. She also conducts health awareness campaigns on non-communicable diseases like hypertension and diabetes.

A strong advocate of the rational use of medicines, Lawal has collaborated with and effectively delivered various local and international level projects with several international organisations, institutions and pharmaceutical companies since 2005. She is very innovative in the practical solutions she has brought to the effective practice of community pharmacy, patient involvement, and patient care. She is also a seasoned researcher and well-published author in peer-reviewed journals.

In recognition of her contributions to the pharmacy profession, Lawal won the May and Baker Professional Award in Pharmacy in 2015, as well as the Commonwealth Professional Fellowship, in the same year. This is  in addition to being a Fellow of the Pharmaceutical Society of Nigeria (FPSN), as well as being a member of the Faculty, Omron Academy; member, Sanofi Advisory Board; and associate member, Royal Pharmaceutical Society.

She is happily married with children.

Health, COVID-19 Take a ‘Back Seat’ at G-7, Experts Says

0
New booster COVID-19 vaccine candidate effective against Omicron subvariants, Moderna says
Approved emergency use of COVID19 Vaccine

In their communiqué, G-7 leaders reaffirmed their commitment to enable global access and delivery of lifesaving tools such as vaccines to overcome the pandemic, tackle antimicrobial resistance, and step up efforts on pandemic prevention, preparedness, and response.

They also reiterated their support for the Access to COVID-19 Tools Accelerator; the establishment of a new financial intermediary fund housed at the World Bank for pandemic prevention, preparedness and response; polio eradication efforts; and the successful replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

But some experts say the statements don’t go far enough to realize ending the COVID-19 pandemic.

“After a year of broken promises over equitable access to COVID-19 vaccines, tests, and treatments, these platitudes from G7 leaders ring hollow,” Julia Kosgei, policy advisor to the People’s Vaccine Alliance, said in a statement.

The G-7 spoke of exceeding their commitment in 2021 in terms of sharing vaccine doses, saying they’ve made available to date more than 1.175 billion vaccine doses. Data from March 2022 – the latest one available – from the Multilateral Leaders Task Force on COVID-19 showed however that millions of confirmed donations have yet to be received by countries.

Kosgei also said that if the “G7 leaders actually want to save lives, they can immediately extend the limited patent waiver agreed for COVID-19 vaccines to also cover lifesaving treatments.” The recent agreement at the World Trade Organization limits waiving patents to COVID-19 vaccines.

Commitments to deliver on the vaccine doses, and meet ACT-A’s current funding needs, were missing, said Cynthia Liao and Theo Beal, Academy for Leadership fellows at Chatham House.

“One year on, economic and security priorities have pushed health priorities into the back seat even while the world is still in the midst of a global pandemic. This is coherent, given the multiple crises facing the world today especially in developing countries. But it is dangerous to slow investments in COVID-19 response when cases are surging and new variants emerging,” they told Devex via email.

“G7 countries seemed to have forgotten the lessons from the pandemic and should be aware of risks from deprioritizing global health issues,” they added.

A source familiar with the discussions shared the same concerns, saying leaders have “deprioritized pandemic prevention and ending the current Covid pandemic.” There wasn’t even a separate summary or annex on health — which was the case for other issues, such as the war in Ukraine and on global food security, the source said.

The G-7’s Partnership for Global Infrastructure and Investment, which formally launched this week, however, includes health as a pillar. According to a White House fact sheet, this includes developing and upgrading health systems infrastructure as well as investments in the health workforce and in the manufacturing of vaccines and other essential medical products.

 

WHO Concerned of Monkeypox Spreading to Children, Pregnant Women

0
WHO to Rename Monkeypox, Publishes Guideline on Vaccination
New Monkeypox Logo as uploaded by WHO

The World Health Organization expressed concerns about monkeypox spreading to vulnerable populations, as more cases continue to be reported in multiple countries.

On Wednesday, WHO Director-General Tedros Adhanom Ghebreyesus said in a press briefing that the virus has now been identified in more than 50 new countries and that trend is likely to continue.

“I’m concerned about sustained transmission because it would suggest that the virus is establishing itself, and it could move into high-risk groups, including children, the immunocompromised, and pregnant women,” Tedros said. “We’re starting to see this with several children already infected.”

WHO is aware of two cases of monkeypox in children in the United Kingdom, and is following up on reports of cases in children in Spain and France.

Meanwhile, according to WHO Chief Scientist Dr. Soumya Swaminathan, immunocompromised individuals are at the highest risk of death from monkeypox.

Tedros said countries should increase their surveillance by increasing testing as quickly as possible, take a best practice approach to manage their response, engage communities actively, and ensure equitable access to medical countermeasures such as vaccines and antiviral medicines.

Vaccines offering protection for smallpox and monkeypox are currently limited in supplies, with stocks available in a few countries such as the United States.

Monkeypox cases have been on the rise in DRC in recent years, WHO says

Interaction between humans and animals may be causing an increase in cases, according to the World Health Organization.

Dr. Michael Ryan, executive director of WHO’s health emergencies program, said countries with stockpiles of these vaccines, including the U.S., have expressed willingness to share their supplies, and WHO is exploring the possibility of distributing them. But regulatory and ethics authorities in countries would have to look into the use of the vaccines and weigh their risks and benefits, particularly when considering their use among vulnerable populations such as pregnant people.

WHO is currently not recommending mass vaccination for monkeypox, but to targeted high-risk groups: preexposure prophylaxis for health workers and laboratory personnel at risk of exposure, and post-exposure prophylaxis for close contacts of cases.

“We can provide the data, we can provide the science, but national regulatory authorities must be able to look at the risks versus the benefits,” Ryan said, reiterating the need for researchers and regulators to come up with common standard protocols for the use of antivirals and for the use of vaccines.

This will enable their use “in the safest possible way — should it be needed — and that we can collect the data needed to ensure that we advance our scientific knowledge on efficacy and on safety,” he added.

Access to Forex, Most Urgent Need of Pharma Manufacturers- Neimeth MD

0

 

 

Access to Forex, Most Urgent Need of Pharma Manufacturers- Neimeth MD
Pharm. Matthew AzojI

Pharm. Matthew Azoji, managing director of Neimeth International Pharmaceuticals Plc., is one man who turns challenges into success stories. A Fellow of the Nigeria Academy of Pharmacy (NAPharm) and recent recipient of the National Productivity Order of Merit (NPOM) Award, Azoji, alongside his management team at Neimeth, have transformed the company from a struggler to a highflier in the Nigerian pharmaceutical space. In this exclusive interview with Pharmanews’ duo of PATRICK IWELUNMOR and ADEBAYO OLADEJO, he shares his Neimeth experience, while also baring his mind on sundry issues affecting the Nigerian pharmaceutical sector. Excerpts:

What would you say have been the factors driving you to offer the kind of progressive leadership Neimeth is enjoying now? 

When I joined Neimeth in February 2019, I took notice of two key issues. One, the company had had about three CEOs in less than eight years, prior to my taking over the leadership of the company. Two, for over a decade it had recorded predominantly huge losses, and low turnover and had not paid dividends to shareholders for nearly ten years. These were two potential worries for any fresh executive management. But instead of looking at these developments negatively, I saw them as key learning points around which our success would be assessed.

Again, whenever I join an organisation, my first step is always to review the strategic plan of the company.  So, one of the first things we did as a new management was to review Neimeth’s corporate strategy. We organised a Board and Management retreat for that purpose. At the end of that exercise, we came up with a new 5-year strategic plan, which included a brand new vision, mission and core values. We are currently in the middle of the 5-year plan and we are seeing positive results.

Our current vision is “to be the leading innovative healthcare provider out of Africa”; while our mission is “to promote healthy confident living”. One of the ways we have carried on is to seek staff buy-in of the new vision and mission. You know that whatever goals you set out as Management, you must carry your staff along. So, we went ahead to develop a set of new core values for the company, aimed at remoulding the character of Management and staff towards the effective pursuit of the vision and mission. These are behaviours around the work environment and conduct of the company business which our workers must exhibit. These attitudes and behaviours are central to high productivity, efficiency and achievement of excellence at work. Our core values include customer delight, leadership, innovation, teamwork, God-consciousness, integrity and community.

After setting up this work framework, we began to implement key elements of our strategy. One major focus has been continuous productivity enhancement. We focused on achieving higher revenues and consistency in the growth of both turnover and profitability. Overall, we have had to put a lot of emphasis on how to delight all stakeholders of the business, building on the mindset of customer delight – in other words, looking at every stakeholder as a customer.

But we also noted that productivity could not be increased to achieve the targets we had set, using some of the aged machines and production facilities in our factory. So, with the approval of the Board, we decided to replace these machines and upgrade the entire production process. In 2020 we began a programme of factory upgrade of our Lagos plant. This is expected to be completed soon. At the end of the exercise, we hope to achieve a 300 per cent increase in production capacity.

So, using your words, we have progressively led Neimeth to attain heights in the last three years which have received commendations from various industry watchers, as evidenced by the various awards we have received since 2019.

Let me also say that whatever results we have achieved so far are the handiwork of the entire Neimeth team, which comprises the Board, Management, and staff, with the support and cooperation of other key stakeholders, such as customers, suppliers, regulatory bodies, relevant government agencies and our communities. But above all these, Neimeth believes in the God-factor. One of the core values of Neimeth is God-consciousness. We attribute whatever success we have achieved in the last three years to the grace of God and we give Him all the glory.

How would you rate the Nigerian pharmaceutical space in terms of innovation? 

Innovation is key to the pharmaceutical industry. It is through innovation that key breakthroughs are made in the global pharmaceutical sector. You cannot develop a novel therapeutic agent to address any critical health need without innovation. On the other hand, innovation in the pharmaceutical industry is achieved mainly through Research and Development (R&D) and through consistent investment in infrastructural and technological development.

The African Union Study Project Report, titled “Strengthening Pharmaceutical Innovation in Africa” defined pharmaceutical innovation as “the discovery, development, production and delivery process that enhances the availability of medical products and people’s access to them”. “Medical products” in this context include diagnostics, drugs, vaccines and medical devices.

One key objective of pharmaceutical innovation established in this definition is access to medicines for people. Access to medicines is a well-established universal human right, but one that is far from being guaranteed for the majority of people in low-income countries, including Nigeria and the rest of Africa.

 

How does this reflect in the Nigerian pharma sector?

My answer is that, in consideration of the above definition and, particularly, in terms of modern medicines and the discovery of molecules and candidate medicines, the Nigerian pharmaceutical space still has a lot to do. We have not done enough as stakeholders in the Nigerian pharma space and the current outcome achieved is not satisfactory, especially if you consider that the Nigerian pharmaceutical space is nearly a century old.

Indeed, there have been efforts in various sectors of the Nigerian pharma space to discover and develop medicines that will address the unique health needs of Nigerians, especially relying on indigenous phytomedicines; but this has resulted in few successes of such discoveries getting to the stage of manufacturing and delivery to end-users. The reasons for this situation have been a combination of economic, infrastructural and technological constraints. The other challenge is the poor level of collaboration and partnership among researchers, policymakers and pharmaceutical manufacturers. There is a lot of communication gap among the various players in this space, leading to long lead times before effectively harnessing the benefits of work already successfully done; and, at the end of the day, the patient suffers. Yet the country houses a large stock of herbal and natural products that can be developed as medical commodities.

 

What is the way out of these lapses?

I think the solution to this will be multi-layered. First, the government must encourage investment in pharmaceutical R&D, through special grants and loans to universities, research institutes and pharma companies. But above all, there must be collaboration between the research institutes and manufacturers on one hand; and among the manufacturers themselves on the other.

While I admit that we need government support to make more progress in these areas, I also think we need more collaborations and organised partnerships among the local operators within the healthcare sector. Few pharmaceutical companies can team up to develop local medicaments working with local researchers for locally made remedies to health emergencies. Now, Neimeth is one of those companies in this country that are focused on developing quality medicines for Nigeria and Africa with an emphasis on Africa specific diseases.

With our new vision – “To be the leading innovative healthcare provider out of Africa” – Neimeth is reinvigorating its effort to build on past achievements and put safer, quality and efficacious remedies at the disposal of Africa and Nigeria; in particular, to effectively deal with the many healthcare challenges besetting the people.

Neimeth has committed a substantial amount of money to Research and Development (R&D) in the recent past. This flows from Neimeth’s vision statement, “To be a leading innovative healthcare provider out of Africa” as indigenous research is one of the key drivers of our innovation. Our innovation strategy includes working with medical and pharmaceutical scientists/researchers to develop new products, and conduct drug clinical trials and in-vitro drug studies. These drugs could be natural, and/or chemical (synthetic), oral, or parenteral.

To this end, we review research work in our indigenous universities and relevant government agencies, based on local raw materials, focusing on specific disease areas that are generally neglected by the global/multinational companies. We seek to provide new local health remedies in these areas at affordable costs.

Our first success in this area is Ciklavit, the first homegrown natural product for the effective management of sickle cell disorder. It is a product of research done at the University of Port Harcourt by late Prof. G.I. Ekeke. Neimeth took up that research and developed Ciklavit, which is one of the most important medicines for  sickle cell disorder today.  Prof Ekeke is late, but we are still paying his family royalties. There are still other projects going on like that – from our farms and gardens, to developing effective medicines.

Secondly, dependence on foreign Research & Development can be minimised by government funding. It is, therefore, heartwarming that the Central Bank of Nigeria (CBN), with the advent of COVID-19, has floated the Health Sector Research and Development Intervention Scheme (HSRDIS), to help strengthen the public healthcare system with innovative financing of Research and Development (R&D) in new and improved drugs, vaccines and diagnostics of infectious diseases in Nigeria.

The scheme is expected to activate passionate national research and development activities that could lead to the development of Nigerian vaccines, drugs and herbal medicines against COVID-19 and any other communicable or non-communicable diseases through the provision of grants to eligible researchers and organisations. The limit of the grant is N50 million for research activities and N500 million for development/manufacturing activities.

Though the Government has demonstrated that something positive could be done in this area by floating the HSRDIS and finally approving grants to 5 researchers totaling about N234.5 million, but some experts in the pharma sector have opined that the amount offered per researcher and per development/manufacturing activity may not be adequate to achieve meaningful outcomes in terms of going from R&D to delivery of medical products to people.

However, the Government can build on this unprecedented gesture by CBN to do more to promote pharmaceutical innovation and by also releasing the grants to organizations for development and manufacturing activities. Besides new product innovation, a lot is also happening in the distributive and supply chain arm, aimed at delivering medicines; especially delivering life-saving medicines to hard-to-reach communities, in a timely manner, using drones, for instance. These kinds of innovation in pharma supply chain help to improve patient outcomes. All stakeholders in the Nigerian pharma space are encouraged to invest more resources in innovation to enhance access to medicine and thereby improve patient outcomes.

Hospital Pharmacists Condemn MDCAN’s Rejection of Amendment to University Teaching Hospitals Act

0

– Say it negates global best practices

Hospital Pharmacists Condemn MDCAN's Rejection of Amendment to University Teaching Hospitals Act
AHAPN’s logo

Pharmacists under the aegis of Association of Hospital and Administrative Pharmacists of Nigeria (AHAPN) have decried the recent outcry of members of Medical and Dental Consultants’ Association of Nigeria (MDCAN) against the proposed Bill seeking amendment to the University Teaching Hospitals Act, Cap U15 LFN 2004, stating that such movement negatives global best practices.

Recent reports attributed to the President of MDCAN, Dr Victor Makanjuola, stated that the association rejects the Bill to amend the University Teaching Hospitals Act, noting that the training of the medical and dental professionals gives them a holistic view of all aspects of patient management.

Reacting to the development, hospital and administrative pharmacists, through a press release signed by the National Chairman, AHAPN, Pharm. Olabode Ogunjemiyo and made available to pharmanewsonline, expressed their utter amazement to the antagonism of the Bill by MDCAN, questioning its mission as “cog in the wheel of progress” of the nation’s comatosed healthcare delivery system.

Contrary to MDCAN’s view, AHAPN maintained that the proposed Bill is to reposition and revive Nigeria’s deteriorating health system that has placed her health indices among the worst in the global ranking of the health indices, 189th position out of 191 countries that were rated. It is so pathetic that in spite of the billions of naira being pumped into the health sector, the health indices have continued to nose-dive.

According Ogunjemiyo “It therefore, sounds very absurd and unimaginable how MDCAN will act as a “cog in the wheel of progress” of our health system by accusing the non-physicians of being the brain behind sponsoring of this bill. The bitter truth is that Nigeria and her citizenries are bigger than the selfish interest of MDCAN who will never ever want the wind of positive change blowing across the globe to blow in our health system.

“What should be utmost importance to the MDCAN should have been to restructure and reposition our Health System to be in line with the International Best Practices to avert the causes of unnecessary and frivolous medical tourism as is being witnessed today due to our faulty health system.

“Contrary to the erroneous claims by the MDCAN that such proposed Bill portends serious present and future risks to the effective running of the Federal Government Tertiary Hospitals with the consequential poor outcomes on our patients, this proposed Bill intends to do the contrary. It is on record that countries operating such or similar proposed structure have demonstrated an undebatable, conspicuous and incontrovertible evidences of positive health impacts on their citizens.

“Countries like US, UK, Canada and many other African countries practicing the proposed system have unequalled or unparalleled enviable height in terms of far better health indices, more accessibilities to health and better health coverage for their citizenries. No country or society will continue to fashion or reposition its health system primarily based on history of evolution of various professions but based on the present or future realities.

“Even judging from the history of the evolution of the various health disciplines, it is undisputable that the origin of health actually emanated from the use of herbs (drugs) which is pharmacognosy as seen in pharmacy. Without dispute, pharmacy as a profession has even existed before the advent of surgery and the so called Medicine and Surgery as a field. No wonder the Ibos call the hospital “Ulo ogwu” (House of Drugs) just like other tribes do”.

The AHAPN National Chairman, explicitly explained the essence of the proposed Bill, saying having observed a lot of anomalies in the Nigerian Health institutions as compared with the happenings in other climes with better health indices, one of the honourable members of the House of Representatives, Honourable Bamidele Salam, decided to sponsor a Bill that will project the Nigerian health system into the trajectory of best countries with global best practices as obtained by many countries like UK, Canada, USA.

The bill, according to him, is meant to amend the University Teaching Hospitals (reconstruction of boards, etc) Act Cap U15 LFN 2014. Among other things, it seeks to: change the nomenclature of the heads of tertiary health institution in Nigeria from Chief Medical Director; Redefine the qualifications of the Head of Tertiary Hospitals; Provide a definite tenure of office for the Head of the Tertiary Hospitals; Include students of Health Sciences in the training programmes of tertiary hospitals; Include hospitals established post-enactment of the extant legal framework in the schedule and for other related matters and restructure the composition of the Governing Boards of Federal Government Tertiary Hospitals.

He further argued that globally, the structure in the hospital is such that most hospitals are headed by those called “Hospital Administrators or Hospital President” which could be anyone who has the requisite skills, knowledge and experience. Such requisite skills, knowledge and experience are far beyond what any group of health professional could lay monopoly of. Such skills, knowledge and trainings are beyond what one can gather solely from any medical, pharmaceutical, nursing or any other school. They are more than the clinical skills, knowledge or training needed to handle patients, drugs etc.

To effectively head a hospital, Ogunyemiyo averred that such a person must have possess some administrative, human resources, economic, psychological etc skills, trainings, knowledge and experience. “Knowledge of handling a stethoscope is not and never synonymous to heading a hospital. The insistence by MDCAN that such a post must be its exclusive reserve runs in sharp contrast to the global norms. Again, in most hospitals, the head of pharmacy (Director of Pharmaceutical Services), Director of Nursing Services and other heads of other clinical and non- clinical services directly report to the Hospital Administrators or Hospital President in matters relating to administration and not passing through a physician”.

Additionally, he made a comparison of the situation to what obtains abroad saying in the provision of care to the patient, the physician remains the head of the medical team and not the hospital administrator which is always thrown open to relevant professionals with the requisite knowledge, skills/trainings. In fact, most hospital administrators are accountants or lawyers etc abroad. Among the clinicians, more nurses head the hospitals than any other clinician in countries like Canada. The existence of Hospital Administrators has even allowed the core clinicians to concentrate more attention to providing medical, pharmaceutical, nursing, nutritional, psychological etc care to patients.

“It is also unbelievable and shocking to listen to the argument by the physicians that this purposed bill, which is targeted to uplift the health standards of most Nigerians by guaranteeing full care (medical, nursing, pharmaceutical, nutritional, etc), is being jettisoned by the body of Nigerian physicians.

“It also very insulting and a mark of highest level of ignorance for a body of Nigerian physicians to project the highly noble efforts of members of the National Assembly as an attempt to strangulate and suffocate the already comatose Nigerian state of health. Why must our physicians continue to enjoy the current lopsided structure of health system which bleed most of our patients financially and deprive them of most collaborative care from other core clinicians?

“Let it be known and re-iterated that Nigeria is bigger than any group of people, hence Nigeria must not be left behind in the current wind of positive change blowing in our health system.MDCAN, APCOM etc should even be the ones who should have initiated this wonderful Bill which is meant to bring life into the comatose nature of our present health system” he quipped.

Igbinedion Varsity Begins PharmD September

0

– Restates commitment to excellence in pharma education, practice

Igbinedion Varsity Begins PharmD September

 

 

The Dora Akunyili College of Pharmacy, Igbinedion University, Okada, Edo State is set to commence the Doctor of Pharmacy (PharmD) programme, following its approval by the National University Commission (NUC).

Disclosing this to Pharmanews recently, Dean of the college, Prof. Ighodaro Igbe, said the university will start admitting its first set of students into the newly approved programme in September for the 2022/2023 academic session.

Igbe further stated that the vision of the university is to make its College of Pharmacy internationally acclaimed for research, education and practice, while training the next generation of pharmacists in an inclusive, collaborative and welcoming environment.

In a related development, Igbe declared at a recent public lecture organised by the college that the vision of the university is to make its College of Pharmacy internationally acclaimed for research, education and practice, while training the next generation of pharmacists in an inclusive, collaborative and welcoming environment.

Speaking at the lecture, themed “The Impact of Standards on the Practice of Pharmacy Profession”, with the Director General, Standard organisation of Nigeria (SON), Mallam Farouk Salim as the keynote speaker, the dean also reiterated the commitment of the college to standard pharmacy practice, saying the college had been maintaining high standards in terms of teaching and learning, staffing and infrastructure from inception till date.

The dean also said that the lecture was an opportunity for universities to engage with the government, the business world and the public, to provide information and education, by leading open discussion of issues that confront the nation, the African region and the world at large.

According to Igbe, “The Professional Practice Standards (PPS) are intended to provide guidance on the expected standards of professional behaviour of pharmacists towards individuals, the community and the society.

“As pharmacists, high standards are expected of professionals in delivering our services to individuals and society at large. The standards of the Pharmacy practice should never be compromised. To this end, the college is fully accredited by the National University Commission (NUC) and the Pharmacists Council of Nigeria (PCN).

“Since the inception of the college in the 2004/2005 session, Dora Akunyili College of Pharmacy has demonstrated an enviable reputation for producing pharmacy graduates with great prospects of practising in different fields, such as academia, hospital, industries, administration, research and in other human endeavours.”

Commenting on the college’s efforts towards research, Igbe said, “The university management has awarded the college, a research grant worth N5 million, with an initial take off grant of N2.5 million. With this grant, the college’s Cancer and Reproductive Research group is currently working on isolation, characterisation and structure elucidation of isolated bioactive uterotonic compounds from natural products useful in easing labour, reducing postpartum haemorrhage, as well as mother/child mortality/morbidity.”

On staff development, the dean said, “Some members of staff are currently enjoying university-sponsored postgraduate, postdoctoral and research fellowships in different parts of the world. Currently, the Head of Department of Pharmaceutical Microbiology is on study leave with pay for a postdoctoral fellowship.

The university management has recently built an automated line situated in the college for the production of disinfectants, antiseptics and laboratory reagents. We have commenced production to meet the immediate aseptic needs of the university. It is also expected that this will become of the major source of IGR for the university.”

In his keynote address at the lecture, the SON DG said standards are particularly more crucial in the pharmaceutical sector given its role in the care of the weak and ensuring that pharmacy practice has zero tolerance for error.

Salim revealed that SON, in collaboration with the ARSO, has developed over 10 standards on african traditional medicine for use in Nigeria. This, he said, is in line with the World Health Organisation (WHO) Traditional Medicine Strategy 2014-2023, aimed at building knowledge base and formulating national policies.

The SON boss noted that in spite of the great potentials of the pharmaceutical industry in Africa, only 3 percent of medicines are locally produced in Africa.

He added that the target of the Nigerian pharmaceutical industry to provide 60 percent of pharmaceutical products consumed by West African countries is largely dependent on regulatory requirements.

His words: “Given the wide scope of the pharmacy profession which includes the synthesis, efficacy testing, formulation, manufacturing, dispensing, and clinical assessment of drugs as well as handling, you can begin to see the relevance of standards in the pharmacy profession.

“Standards are also applied in the pharmaceutical industry to ensure the strength of the active ingredient quality and purity of drugs and other pharmaceutical products. They ensure safe and effective products for patients and form the basis for the regulatory requirements for industrial practice which ensure quality in the entire chain of drug production to its distribution.”

Salim added the agency is always ready to support the pharmaceutical industry with relevant standards and information on international best practices aimed at overcoming technical barriers to trade.

Why “Auxiliary Nurses” and their Trainers Deserve Arrest, Prosecution- Chairman, NANNM-Lagos

0

 

Why “Auxiliary Nurses” and their Trainers Deserve Arrest, Prosecution- Chairman, NANNM-Lagos
Julius Olurotimi Awojide

Julius Olurotimi Awojide is the chairman, National Association of Nigerian Nurses and Midwives (NANNM) Lagos State Chapter. He is also a maternal and child specialist at the Lagos State Health Service Commission. In this exclusive interview with TEMITOPE OBAYENDO, he amplifies the call by nurses in the state against quackery and intrusion of charlatans, irrespective of the acute shortage of nurses. He also examines other issues affecting the practice of the profession in the state. Excerpts:

The International Nurses’ Day was recently commemorated. How was the celebration in Lagos?

Lagos NANNM joined other states councils from the 36 states and the FCT to celebrate the International Nurses Week in Abuja, from 5 to 12 May 2022 at NAF Conference Centre, Kado Abuja. Highlights of the event included an outreach programme and advocacy visit to IDP Camp, Wasa, Abuja. This was followed by week-long educational activities at the conference room. Some hospitals in Lagos State also joined in the celebration with various activities.

 

What is NANNM’s stance on the number of nurses available for the country’s huge population?

In order to address the number of nurses available for the large population, NANNM is collaborating with the Nursing and Midwifery Council of Nigeria (NMCN) in their efforts to increase the students’ admission quota into our various schools of nursing. The NMCN has also introduced the Licensed Community Nurse and Licensed Community Midwife programmes into its scheme.

Lagos NANNM has also recommended that automatic employment be given to the graduates of Lagos State School of Nursing, Igando. This, we believe, will cushion the effects of shortage of nurses in the state. The state government has equally approved exit replacement, as well as regular employment of more nurses.

With the acute shortage of nurses in the state, what’s your take on employment of informally trained nurses as assistants in the hospitals?

Lagos NANNM is against quackery in whatever form. Nursing is about rendering evidence-based care and this requires rigorous academic and professional training. Lagos NANNM recommends the arrest and prosecution of anyone engaging in the training of any cadre of nurses without express approval/accreditation by the NMCN. The word “auxiliary nurse” is not known to law in Nigeria and Lagos NANNM shall not support illegality.

Are there efforts by NANNM to improve nurses’ attitude to work, in comparison to their counterparts abroad?

Lagos NANNM is engaging with the government to reduce the burden of overwork among nurses. Evidence has shown that overworked nurses may suffer from fatigue or burnout, which can impair ability to focus on tasks. And this lack of focus can lead to medical errors, a lack of engagement and missed nursing care.

We have equally been engaging our nurses in various forms of training, both virtually and physically. We encourage every nurse to posses the following attitudes: intent, reflection, curiosity, tolerance for ambiguity, self-confidence and professional motivation, as postulated by Keith Rischer.

According to the theme for this year’s celebration, “Nurses: A Voice to Lead – Invest in Nursing and Respect Rights to Secure Global Health”,  we are advocating for more investment in Nursing through training and retraining, improved working conditions and more welfare packages.

What are the motivating factors abroad? Let us emulate this for the improvement of nursing care services.

 

 

 

Kogi Specialist Hospital to Recruit Doctors, Consultants – CMD

0

 

 

Kogi Specialist Hospital to Recruit Doctors, Consultants – CMD

 

The newly renovated Kogi Specialist Hospital is set to employ more doctors, consultants and nurses for effective and efficient service.

The Chief Medical Director of the Hospital, Prof. Isah Adagiri-Yahaya, made this known in an interview with newsmen in Lokoja on Thursday shortly after Gov. Yahaya Bello visited and inspected the renovated hospital.

“With the turnaround of the hospital by our hardworking governor, we are set to employ more doctors, consultants, nurses, lab scientists, amongst others, to give the general public better services.

“In fact, with the kind of facilities we have now, they (public) should expect better services from us; more so that the governor has given us a standing approval to employ qualified and determined staff.

“We presently have 50 doctors in our 14 departments and each of the departments must have a consultant.

“We have four consultants in Optics and Gynaecology, ENT Surgeon, General Surgeon, Opthalmology and Psychiatric but we need more of them,” he said.

Adagiri-Yahaya expressed gratitude to the governor for ordering for the purchase a Citi-Scan Machine and an Advanced Life Support Mobile Clinic or Ambulance for the hospital.

He said that the ambulance, which had all the necessary facilities, would soon be delivered to the hospital alongside the Citi-Scan Machine.

He said that once they arrived. they would be kept at the newly constructed Diagnostic Centre.

According to him, the Citi-Scan Machine will go a long way in helping accident victims and cancer patients in and outside the state. (NAN)

Monkeypox: Anambra Confirms One Positive Case

0

 

Monkeypox patients

The Anambra State Government says that one out of the two suspected cases of monkeypox reported in the state has been confirmed positive.

The state’s Commissioner for Health, Dr. Afam Obidike, disclosed this at a news conference in Awka on Thursday.

Obidike said that the state had been on alert mode following the report of the disease early this year across some states in the country.

According to him, the state emergency preparedness and response team put all the relevant surveillance measures in place toward ending the spread of the outbreak.

“A few weeks ago, two suspected cases of monkeypox were reported in Anambra East, Onitsha, and Oyi Local Government Areas (LGAs), out of which the case from Anambra East LGA was confirmed positive.

“The case is currently at the isolation centre of the Nnamdi Azikiwe University Teaching Hospital, Nnewi, where he is receiving treatment and recovering.

“In light of the above, Governor Charles Soludo immediately declared the incident an outbreak, and an emergency preparedness and response committee meeting was convened on Wednesday.

“The meeting was attended by relevant stakeholders including the World Health Organisation team and the United Nations International Children’s Emergency Fund. They are providing necessary assistance to the state.

“Planning for immediate response to the outbreak and surveillance, laboratory, case management, risk communication and community engagement, infection prevention and control and safe burial pillars, were activated,” he said.

Obidike said that the state government had commenced the training of health personnel and response officers on enhanced active case search, sample collections and monkeypox management as well as intensifying public awareness.

He urged residents not to panic and report to the hospital for proper examination whenever they notice rashes on their skin.

“Once it is established at the hospital, the patient will be taken to our isolation centres for treatment. We have activated all our Isolation centres in the state.

“We urge residents to remain calm and stay safe as we mitigate this outbreak of monkeypox in the state. We shall overcome again,” he said

Also speaking, Dr. Adamu Abdulnasir, Anambra state Coordinator, WHO, said the organisation would support the state in terms of outbreak response and surveillance and capacity building.

“Since we heard about the two suspected cases, WHO has supported in the areas of sample collection and taking the sample to the laboratory.

“When the results came out, we carried out contact tracing as well as case and risks management.

“In Nigeria so far, we have recorded 41 cases of monkeypox with one death. The government is taking proactive measures to bring this outbreak to a stop and sensitise people on how to prevent and protect themselves,” he said.

The News Agency of Nigeria reports that monkeypox is an uncommon disease caused by infection with the monkeypox virus, which belongs to the orthopoxvirus genus in the poxviridae family.

(NAN)

Phytomedicine and Family Health

0

 

Phytomedicine and Family Health

 

Defined simply as medicine based on plants, phytomedicine has played a largely complementary role to orthodox medicine in the management of both common and complicated disease conditions. In countries like India and China, it is a very popular branch of medicine that has become part of the national healthcare deliery system. Many families in these climes depend on medicinal plants for the management of common ailments. The Indian Ayurveda system of medicine depends largely on plants and can be seen as another aspect of phytomedicine, even though it also includes diet and yoga.

Data gathered from different parts of the world suggests that there are about 35, 000 plants species that are being used as medicines in the form of herbal therapies and recipes. Of these, researchers say about 20 per cent undergo the stage of phytochemical analysis, while 10 per cent reach the biological screening stage. The remaining require some level of exploration through the use of modern technologies.

Some of the most significant values of phytomedicine lie in the fact that plants can offer both prophylactic and therapeutic benefits. This has helped many families cope with the harsh economic implications of accessing modern healthcare. In India and most of Asia, as well as Africa, ailments like the common cold do not necessarily require visiting the hospital, as families cultivate gardens from where they harvest medicinal plants for their wellbeing. For instance, plants like ginger, garlic, turmeric, lemon and clove have shown remarkable promise in the prevention and treatment of flu and other common cold and feverish conditions.

The popular Chinese tea has become a much sought-after commodity all over the world, largely because of its therapeutic qualities. Known to be full of catechins, Chinese tea helps to speed up the fat-burning process. It also enhances muscle gain and increases muscle endurance in the process. The benefits of increased muscular endurance are many and include reduction in the risk of injury, increase in confidence and increase in physical abilities. It is therefore a good recipe for sports people and all those who wish to keep fit.

The leaves of Mangifera indica, a particular species of mango, have been used in healing practices like Ayurveda and traditional Chinese medicine for thousands of years. Although the stem, bark, leaves, roots, and fruit are likewise used in traditional medicine, the leaves in particular are believed to help treat diabetes and other health conditions.

In Nigeria, phytomedicine is becoming popular among families. Notwithstanding, experts have raised concerns bordering on dosage and administration, arguing that it is not enough for plants to be considered medicinal and consumed arbitrarily, bearing in mind the potential dangers inherent in the activities of charlatans who call themselves herbal medicine sellers.

There is no doubt that certain plants in Nigeria have offered therapeutic benefits to individuals and families. The problem is that people have the tendency to abuse the process. Thus, if medicinal plants must be included in a family’s health regimen it must be with the guidance of a nutritionist or a medical practitioner.

In the management of diabetes in Nigeria and other African countries, the bitter leaves of the neem tree have been found to show significant promise as they are loaded with flavonoids, triterpenoid, anti-viral compounds and glycosides which may help manage blood sugar levels.

The management of sickle cell in Nigeria recorded a major breakthrough with the discovery of the therapeutic power of the edible pigeon pea (Cajanus Cajan) by the late G.I. Ekeke of the University of Port Harcourt. Interestingly, Neimeth International Pharmaceuticals took up that research and developed it into Ciklavit which is one of the most important medicines for sickle cell disorder today.

The benefits of bitter leaf which grows in many homes in Nigeria are numerous and have inspired a lot of scientific research. Farombi and Owoeye, in their 2011 scholarly article, Antioxidative and Chemopreventive Properties of Vernonia Amygdalina and Garcinia Biflavonoid observed that: “Vernonia amygdalina, commonly known as bitter leaf, is a shrub that grows up to 3 meters high in the African tropics and other parts of Africa, particularly, Nigeria, Cameroon and Zimbabawe. It is reputed to have several health benefits. The organic fraction extracts of the plant was shown to possess cytotoxic effects towards human carcinoma cells of the nasopharynx. It is effective against amoebic dysentery, gastrointestinal disorders, and has antimicrobial and antiparasitic activities.”

The contribution of phytomedicine to human health cannot be quantified in terms of benefits. Even the World Health Organisation is quite aware and appreciates the fact that plant-based medications are among the most sought-after primary healthcare for around 3.5 billion people across the globe and there are very strong indications that the demand for herbal remedies will continue to increase.

Nigeria Gets Five New Open Defecation-Free LGAs

0

 

 Nigeria Gets Five New Open Defecation-Free LGAs

 

Five new local government areas have been added to the list of Open Defecation-Free LGAs in the country.

This brings to 83 the number of LGAs in the country now free from having its populace defecating in the open.

They are; Garki, Kaugama, Miga, and Yankwashi in Jigawa, and Aguata LGA in Anambra State.

At the monthly meeting of the National Task Group on Sanitation in Abuja, the members unanimously agreed to declare the five LGAs open defecation-free, after meeting the criteria in the ODF Protocol.

The News Agency of Nigeria, reports that before attaining the ODF status, communities would have eliminated open defecation and imbibed total sanitation practices, which include personal, environmental, and domestic hygiene.

The communities would have also had 100 per cent toilet use and increased ownership and sustainability of hygiene and sanitation services.

Chairman of the NTGS, Mr. Emmanuel Awe, said the validation exercise was part of the process to monitor and encourage communities on behavioural change in hygiene promotion.

According to him, states must show more commitment to ensuring that more LGAs are open defecation-free, and in a sustainable manner.

Giving an overview of processes for the Jigawa LGAs, to be declared open defecation-free, Mr. Peters Ojonuba, the Validation Team Lead, said it was impressive to see the commitment of the state to improving access to sanitation.

Ojonuba said no faeces were sighted in the 414 communities, being 20 per cent of the 2,070 communities in the four LGAs.

He said most communities depended on open wells as the water source, and drop hole covers were used for latrines, adding that this was supported by the state government through subsidy.

“Although few households did not have drop hole clovers, we applied simple immediate doable actions by showing them how to construct it and use it immediately.

“We also observed the correct use of tippy taps and plastic kettles for hand washing, the challenge, however, was the issue of “Ba-Shiga’ (no entry), for some male validators,’’ he said.

He also commended the commitment of the political class and traditional rulers who sanctioned defaulters of the rule of public defecation.

Mr. Chibuike Nwanyanwu, who spoke on Aguata LGA’s efforts towards becoming open defecation-free, said behavioural change evidence was seen in communities building and using their toilets.

Nwanyanwu said communities in the LGA had moved up the sanitation ladder through the use of improved toilets, and called for sustainability of the efforts through constant monitoring.

(NAN)

Vote for the Dean of the Year 2022

609

 

 

Sequel to the nomination exercise for the Dean of the Year 2022, which ended 23 June 2022, specially constituted panel, has conducted background checks on nominees with the highest nominations, who also met the stipulated criteria for the poll.

In view of this, the following candidates have been shortlisted for the online poll: Prof. Aderonke Adepoju-Bello (UNILAG); Prof. Festus B. C. Okoye (UNIZIK); Prof. Kenneth C. Ofokansi (UNN); Prof. Theophine Akunne (COOU); Prof. M.U. Uhumwangho (UNIBEN); and Prof. Uthman G. Sadiq (UNIMAID).

You are to vote for the candidate of your choice among them, while the candidate with the highest votes emerges the winner.

Please note that VOTING CLOSES on 21 July, 2022 at 12: 00 Noon

You can only vote once. The system will prevent you from voting if you have voted before.

HOW TO REGISTER AND VOTE

  1. Click on the register button below.
  2. Fill out the form with your details, Username, Email (valid), Choose User Password and confirm the User Password.
  3. Click on submit ( confirmation link will be sent to your mail )
  4. Login to your mail, click on the link sent to you from pharmanews
  5. Login to pharmanews site with your username and password ( if you are not redirected to the voting poll, click on the Vote for the Dean of the Year 2022 link )
  6. scroll down to the POLL WIDGET (If the poll did not show, click on the Back to Vote button)
  7. Click on the name of your preferred candidate to Vote.
NOTE: Your email must be confirmed

Your comments are highly welcome. However, comments do not count as vote cast

Register Login

 

POLL HAS ENDED

[totalpoll id=”324681″]

Lagos Launches New Guidelines on Abortion

0

 

Lagos Launches New Guidelines on Abortion
Pregnancy Test kit

The Lagos State Government through the Ministry of Health has developed a 40-page policy document tagged “Lagos State Guidelines on Safe Termination of Pregnancy for Legal Indications”, The policy document, recently presented and launched by the state’s ministry of health at a stakeholders’ engagement forum, sets out principles to be strictly adhered to for safe termination of pregnancy within the ambit of the criminal law of Lagos State.

The Permanent Secretary, Lagos State Ministry of Health, Dr Olusegun Ogboye, at the unveiling of the document stated that the conception of the policy was borne out of the need to provide evidence-based data and information for health workers both in public and private sectors who have the requisite skills and training necessary to provide safe terminations to reduce preventable deaths.

He continued stating that while quality and authentic termination of pregnancy is possibly permissible under the guarding laws of Lagos State, the absence of clear guidelines has stalled the effective implementation at appropriate levels of care resulting in preventable deaths.

In his words: “In 2011, the Lagos State House of Assembly updated the criminal code, providing for abortion to save the life and protect the physical health of the woman.  While physical health is covered under the Lagos legal framework, services conforming to the law have not been available in Lagos State health sector.

“This document provides information on relevant laws applicable in Lagos State while providing standards and best practices with regards to legal indications, pre and post procedure care, methods and monitoring. I must state here that this document has undergone wide consultation with relevant technical stakeholders within the legal and health service context in the State”.

Ogboye  emphasised that the intent and procedure to develop the guidelines had long commenced in 2018 with the Safe Engage project led by the Lagos Ministry of Health and hosted by the Society for Obstetricians and Gynaecologists of Nigeria (SOGON), with a strong support from Population Reference Bureau (PRB).

He said: “To guide the implementation, one of the follow up recommendations of the project was the adaptation of the National Standards and Guidelines for Safe Termination of Pregnancy within Legal Indications within the Lagos State context. The Federal Ministry of Health had developed and disseminated the national guidelines on safe termination of pregnancy which highlights the compendium of conditions and circumstances under which termination of pregnancy could be instituted.

“The guideline was intended to build the capacity of health professionals to identify pregnancies for which legal termination could be instituted.  Marie Stopes International in Nigeria in collaboration with the Population Reference Bureau proposed to support the State government to adapt the document”.

“All that hand work has culminated in today’s dissemination of the guidelines.  We hope this dissemination today will help guide health providers to provide this service within the ambit of the law”, Ogboye stated.

The Vice-Chancellor of the University of Medical Sciences, Otukpo, Prof. Innocent Ujah,  who was one of the consultants that developed the document affirmed that the declaration, arrangement and use of this guidelines will protect the lives of many pregnant women and women whose physical or mental health would be compromised with the continuation of their pregnancies.

He explained that the guidelines provide information on subsisting Nigeria law on termination of pregnancy, Lagos State revised law 2011, a compendium of medical conditions and circumstances where the continuation of pregnancy endangers the women’s life and describes the step-by-step options for ethical and safe medical management.